<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0055">
    <title>38 Salmonella</title>
    <sect1 id="ch0055s0001">
      <title>38 Salmonella</title>
      <anchor id="ch0055s0001a0001"/>
      <anchor id="ch0055s0001a0002"/>
      <para role="chapterAuthor"><phrase role="center">JOHN P. DEKKER, MATTHEW L. FARON, ROMNEY M. HUMPHRIES, BLAKE W. BUCHAN, AND NATHAN A. LEDEBOER</phrase>
      </para>
      <sect2 id="ch0055s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0055s0001s0001a0001"/>
        <anchor id="ch0055s0001s0001a0002"/>
        <para id="ch0055s0001s0001p0001">The genus<emphasis>Salmonella</emphasis> is composed of two species, <emphasis>Salmonella enterica</emphasis> and <emphasis>Salmonella bongori. S. enterica</emphasis> is, in turn, divided into six subspecies, each designated by a name and group number: <emphasis>S. enterica</emphasis> subspecies <emphasis>enterica</emphasis> (group I), <emphasis>S. enterica</emphasis> subsp. <emphasis>salamae</emphasis> (group II), <emphasis>S. enterica</emphasis> subsp. <emphasis>arizonae</emphasis> (group IIIa), <emphasis>S. enterica</emphasis> subsp. <emphasis>diarizonae</emphasis> (group IIIb), <emphasis>S. enterica</emphasis> subsp. <emphasis>houtenae</emphasis> (group IV), and <emphasis>S. enterica</emphasis> subsp. <emphasis>indica</emphasis> (group VI). Serotypes of clinical or epidemiologic importance within each subspecies may also be assigned a common name, such as <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotype Typhi and <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotype Enteritidis, which can be designated <emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Enteritidis. Of note, all <emphasis>S.</emphasis> Typhi strains belong to O antigen serogroup D, which can still be used to putatively identify this serotype (<link linkend="ch0055s0012s0003li0001">1</link>, <link linkend="ch0055s0012s0003li0002">2</link>). DNA-DNA hybridization experiments demonstrate &gt;80% association among all <emphasis>S. enterica</emphasis> serotypes, which exceeds the accepted threshold of 70% for definition of a species (<link linkend="ch0055s0012s0003li0003">3</link>). <emphasis>S. bongori</emphasis> (group IV) shares only 45 to 50% relatedness with <emphasis>S. enterica</emphasis> and has been designated a separate species (<link linkend="ch0055s0012s0003li0002">2</link>). Within the order <emphasis>Enterobacterales</emphasis>, the genus <emphasis>Salmonella</emphasis> shares the greatest sequence similarity with <emphasis>Citrobacter, Escherichia</emphasis>, and <emphasis>Shigella</emphasis> (45 to 50%), followed by <emphasis>Klebsiella</emphasis> and <emphasis>Enterobacter</emphasis> (30 to 40%), and is least related to <emphasis>Serratia</emphasis> and <emphasis>Proteus</emphasis> (7 to 28%) (<link linkend="ch0055s0012s0003li0003">3</link>).</para>
        <para id="ch0055s0001s0001p0002">The chromosome of<emphasis>S. enterica</emphasis> is 4.3 to 5.0 Mbp and carries 4,500 to 5,400 genes (<link linkend="ch0055s0012s0003li0004">4</link>). The core genome present in all serotypes is 1.5 Mbp; however, &gt;96% of serotypes contain a conserved core genome that is 3.2 Mbp in size, roughly equivalent to 70% of the total genome (<link linkend="ch0055s0012s0003li0005">5</link>). This core genome differs by approximately 1% between <emphasis>S. enterica</emphasis> serotypes and by 10% compared to the core genome of <emphasis>Escherichia coli</emphasis> (<link linkend="ch0055s0012s0003li0004">4</link>). The use of whole-genome analysis has enabled identification of genetic markers unique to each subspecies, ranging from 9 for <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> to 207 for <emphasis>S. enterica</emphasis> subsp. <emphasis>arizonae</emphasis> (<link linkend="ch0055s0012s0003li0005">5</link>). These studies support the earlier DNA-DNA hybridization- and enzyme electrophoresis-based taxonomic organization of <emphasis>S. enterica</emphasis> into six subspecies or groups. Similar whole-genome analysis was unable to establish genetic markers that uniquely identified all serotypes within a subspecies; however, sets of markers universally present or absent from many serotypes were identified. These findings demonstrate the high degree of genetic conservation within <emphasis>Salmonella</emphasis> subspecies but also the heterogeneity that is likely responsible for differences in pathogenicity and antimicrobial resistance characteristics of individual serotypes.</para>
        <para id="ch0055s0001s0001p0003"><emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotypes Typhi and Paratyphi A to C are unique among <emphasis>Salmonella</emphasis> serotypes in both their limited host range and pathogenesis. Genetically, <emphasis>S.</emphasis> Typhi isolates are highly clonal regardless of geographic origin and do not cluster among the other <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotypes (<link linkend="ch0055s0012s0003li0002">2</link>, <link linkend="ch0055s0012s0003li0004">4</link>). <emphasis>S.</emphasis> Typhi has one of the largest sets of universal genetic markers common to <emphasis>S. enterica</emphasis> serotypes but also contains among the fewest genetic markers defining a subspecies (<link linkend="ch0055s0012s0003li0005">5</link>). Both features are indicative of recent divergence within the serogroup followed by genomic decay as this serotype adapted to the human host (<link linkend="ch0055s0012s0003li0004">4</link>). <emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Paratyphi C also express the Vi capsular antigen, which is unique among <emphasis>Salmonella</emphasis> serotypes. This antigen is antiphagocytic and anti-inflammatory and aids in intracellular survival, which contributes to the systemic disease caused by these serotypes (<link linkend="ch0055s0012s0003li0006">6</link>). The presence of this antigen has commonly been used to serologically identify <emphasis>S.</emphasis> Typhi, but Vi expression may be variable based on <emphasis>in vitro</emphasis> growth conditions. Molecular detection of genes involved in regulation and expression of Vi (<emphasis>tviB</emphasis> and <emphasis>viaB</emphasis>) has been employed to definitively identify <emphasis>S.</emphasis> Typhi isolates lacking phenotypic Vi expression.</para>
      </sect2>
      <sect2 id="ch0055s0001s0002">
        <title>DESCRIPTION OF THE GENUS</title>
        <anchor id="ch0055s0001s0002a0001"/>
        <anchor id="ch0055s0001s0002a0002"/>
        <para id="ch0055s0001s0002p0001"><emphasis>Salmonella</emphasis> organisms are motile, non-spore-forming, facultatively anaerobic Gram-negative bacilli approximately 1 μm in width and 2 to 5 μm in length. They can be cultured on most common laboratory media, including Mueller-Hinton agar with or without sheep blood, MacConkey agar (MAC), Trypticase soy agar and broth, and a variety of selective and differential media utilized for isolation of <emphasis>Salmonella</emphasis> from stool specimens (see “Isolation Procedures”). When cultured on 5% sheep blood agar at 35°C, colonies are large, moist, and gray to translucent and may be apparent following as little as 12 to 16 h of incubation. Motility in liquid culture is driven by expression of 2 to 4 flagella and can be observed microscopically as directed movement in wet-mount preparations. <emphasis>Salmonella</emphasis> spp. are capable of swarming motility in semisolid agar (0.5 to 0.8%) via cell elongation and expression of an increased number of flagella; however, swarming is not observed on solid agar (&gt;1.5%) routinely used for bacterial culture in the laboratory (<link linkend="ch0055s0012s0003li0007">7</link>). <emphasis>Salmonella</emphasis> spp. also express a number of pili and fimbriae <emphasis>in vivo</emphasis> that mediate attachment to and colonization of the gastric mucosa (<link linkend="ch0055s0012s0003li0008">8</link>).</para>
        <anchor id="ch0055s0001s0002a0003"/>
        <beginpage pagenum="747"/>
        <table id="ch0055s0001s0002t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0055s0001s0002a0004"/><link linkend="ch0055s0001s0002a0009">TABLE 1</link></phrase></emphasis> Phenotypic traits useful for differentiating <emphasis>Salmonella</emphasis> from other <emphasis>Enterobacterales</emphasis> and identifying <emphasis>Salmonella</emphasis> serotypes Typhi and Paratyphi A<superscript><emphasis><anchor id="ch0055s0001s0002a0005"/><link linkend="ch0055s0001s0002a0007">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="4">
            <tbody>
              <row>
                <entry><phrase role="center">Test</phrase>
                </entry>
                <entry><phrase role="center">Reaction for:</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="center">Nontyphoidal <emphasis>Salmonella</emphasis> subsp. I</phrase>
                </entry>
                <entry><phrase role="center"><emphasis>Salmonella</emphasis> serotype Typhi</phrase>
                </entry>
                <entry><phrase role="center"><emphasis>Salmonella</emphasis> serotype Paratyphi A</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">TSI</phrase>
                </entry>
                <entry><phrase role="left">K/A, g</phrase>
                </entry>
                <entry><phrase role="left">K/A</phrase>
                </entry>
                <entry><phrase role="left">K/A, g</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">H<subscript>2</subscript>S (TSI)</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+<superscript>weak</superscript></phrase>
                </entry>
                <entry><phrase role="left">− or +<superscript>weak</superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Indole</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Methyl red</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Voges-Proskauer</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Citrate (Simmons)</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Urea</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Lysine decarboxylase</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Arginine dihydrolase</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">d</phrase>
                </entry>
                <entry><phrase role="left">(+)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Ornithine decarboxylase</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Motility</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Mucate</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Malonate</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">L</phrase>(+)-Tartrate (<emphasis>d</emphasis>-tartrate<superscript><emphasis><anchor id="ch0055s0001s0002a0006"/><link linkend="ch0055s0001s0002a0008">b</link></emphasis></superscript>)</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">+</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Growth in KCN</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Glucose</phrase>
                </entry>
                <entry><phrase role="left">A, g</phrase>
                </entry>
                <entry><phrase role="left">A</phrase>
                </entry>
                <entry><phrase role="left">A, g</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Lactose</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Sucrose</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Salicin</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Dulcitol</phrase>
                </entry>
                <entry><phrase role="left">A, g</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">A, g<superscript>2 days</superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Inositol</phrase>
                </entry>
                <entry><phrase role="left">d</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Sorbitol</phrase>
                </entry>
                <entry><phrase role="left">A, g</phrase>
                </entry>
                <entry><phrase role="left">A</phrase>
                </entry>
                <entry><phrase role="left">A, g</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>o-</emphasis>Nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Galacturonate</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
                <entry><phrase role="left">−</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0001s0002a0007"/><link linkend="ch0055s0001s0002a0005">a</link></emphasis></superscript>Reactions after incubation at 37°C. Abbreviations and symbols: +, 90% (or more) of strains were positive within 2 days; (+), variable, positive reaction after 3 or more days; −, no reaction (90% or more) in 7 days; A, acid; d, different reactions [+, (+), −]; g, gas; K, alkaline slant; TSI, triple sugar iron. (Adapted with permission from reference <link linkend="ch0055s0012s0003li0002">2</link>.)</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0001s0002a0008"/><link linkend="ch0055s0001s0002a0006">b</link></emphasis></superscript>Sodium potassium tartrate (<link linkend="ch0055s0012s0003li0112">112</link>).</para>
        <para id="ch0055s0001s0002p0002"><emphasis>Salmonella</emphasis> spp. are oxidase negative and ferment glucose with production of gas, with the exception of <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotype Typhi, which does not produce gas. <emphasis>Salmonella</emphasis> spp. are positive for lysine decarboxylase, with the exception of <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotype Paratyphi; &gt;98% of isolates are negative for lactose and sucrose fermentation, indole production, urease, and β-galactosidase (<anchor id="ch0055s0001s0002a0009"/><link linkend="ch0055s0001s0002a0004">Table 1</link>). Over 90% of clinically isolated <emphasis>Salmonella</emphasis> strains produce H<subscript>2</subscript>S, but production by <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> serotypes Typhi and Paratyphi A is scant and negative, respectively.</para>
      </sect2>
      <sect2 id="ch0055s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0055s0001s0003a0001"/>
        <anchor id="ch0055s0001s0003a0002"/>
        <para id="ch0055s0001s0003p0001">Over 2,500 unique<emphasis>Salmonella</emphasis> O:H serotypes are currently recognized worldwide (<link linkend="ch0055s0012s0003li0009">9</link>). <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> (including serotypes Typhi, Paratyphi, Typhimurium, and Enteritidis) encompasses 60% of all serotypes and accounts for over 99% of human infections (<link linkend="ch0055s0012s0003li0009">9</link>, <link linkend="ch0055s0012s0003li0010">10</link>). The remaining five <emphasis>S. enterica</emphasis> subspecies and <emphasis>S. bongori</emphasis> are typically environmental isolates or pathogens of cold-blooded animals and are rarely implicated in human disease (<link linkend="ch0055s0012s0003li0009">9</link>). Gastrointestinal illness, the most common presentation of nontyphoidal <emphasis>Salmonella</emphasis> infection, is estimated to affect nearly 100 million people globally on an annual basis (<link linkend="ch0055s0012s0003li0011">11</link>). This equates to approximately 3% of all cases of diarrheal illness. The regional incidence of infection varies widely from as low as 250/100,000 in Central and North America to 690/100,000 in Europe and nearly 4,000/100,000 in East and Southeast Asia. In the United States, <emphasis>Salmonella</emphasis> spp. are second only to norovirus as a cause of foodborne illness, accounting for &gt;1.35 million infections and &gt;26,000 hospitalizations annually. <emphasis>S.</emphasis> Enteritidis, <emphasis>S.</emphasis> Typhimurium, and <emphasis>S.</emphasis> Newport are the three serotypes most commonly associated with gastroenteritis and account for approximately 50% of reported infections (<link linkend="ch0055s0012s0003li0012">12</link>). The mortality rate associated with nontyphoidal <emphasis>Salmonella</emphasis> infection is approximately 0.1 to 0.5%, but it can vary based on host factors such as nutrition, immunocompromised status, and access to health care (<link linkend="ch0055s0012s0003li0011">11</link>, <link linkend="ch0055s0012s0003li0013">13</link>). Infection with “typhoidal” <emphasis>Salmonella</emphasis>, namely, <emphasis>S.</emphasis> Typhi or <emphasis>S.</emphasis> Paratyphi, causes a systemic illness commonly known as enteric fever, which is endemic in Asia, India, and South Africa. The incidence of enteric fever is highest in Pakistan and India, reaching 200 to 450 cases per 100,000 population, and carries a mortality rate of 1 to 7% (<link linkend="ch0055s0012s0003li0014">14</link>). The incidence of enteric fever in North America and Europe is low, with 70 to 80% of cases occurring in travelers returning from regions of endemicity (<link linkend="ch0055s0012s0003li0013">13</link>, <link linkend="ch0055s0012s0003li0015">15</link>).</para>
        <para id="ch0055s0001s0003p0002">Nontyphoidal<emphasis>Salmonella</emphasis> (NTS) is a common inhabitant of the gastrointestinal tract of wild and domestic poultry, which serves as an important reservoir for infection, but is also frequently isolated from warm-blooded mammals and reptiles. Chronic asymptomatic carriage of NTS by humans following infection is rare, occurring in approximately 1:1,000 cases, but may also serve as a source of infection (<link linkend="ch0055s0012s0003li0001">1</link>, <link linkend="ch0055s0012s0003li0014">14</link>). Between 90 and 95% of all <emphasis>Salmonella</emphasis> infections are foodborne (<link linkend="ch0055s0012s0003li0011">11</link>, <link linkend="ch0055s0012s0003li0013">13</link>); large outbreaks have also been linked to close contact with animals, including “backyard poultry” and pet turtles (<link linkend="ch0055s0012s0003li0016">16</link>). Foods most commonly implicated in transmission of <emphasis>Salmonella</emphasis> are undercooked poultry and eggs; however, fresh produce and processed foods such as chocolate and peanut butter have also been implicated in recent large outbreaks in the United States and Europe (<link linkend="ch0055s0012s0003li0014">14</link>, <link linkend="ch0055s0012s0003li0016">16</link>). In addition, foods can be cross-contaminated if prepared using instruments or surfaces, such as cutting boards, that were previously contaminated. Between 40 and 100% of a <emphasis>Salmonella</emphasis> inoculum can be recovered from wooden or plastic cutting boards within 30 min of contamination, and <emphasis>Salmonella</emphasis> spp. can persist for &gt;24 h on dry surfaces. All <emphasis>Salmonella</emphasis> serotypes are acid labile and susceptible to the low pH of the stomach; therefore, the infective dose via ingestion is relatively high, ranging from 10<superscript>5</superscript> to 10<superscript>10</superscript> viable organisms (<link linkend="ch0055s0012s0003li0017">17</link>). The variance in infective dose may be serotype specific and is likely impacted by the food vehicle, with high-fat foods and milk conferring a lower infective dose due to neutralization of stomach pH.</para>
        <anchor id="ch0055s0001s0003a0003"/>
        <beginpage pagenum="748"/>
        <para id="ch0055s0001s0003p0003"><emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Paratyphi are strict human pathogens and have no animal or environmental reservoirs. They may be more susceptible to environmental stresses than other serotypes and remain viable for only 6 h on inanimate surfaces (<link linkend="ch0055s0012s0003li0018">18</link>). Up to 5% of individuals infected with <emphasis>S.</emphasis> Typhi or <emphasis>S.</emphasis> Paratyphi become chronic asymptomatic carriers, shedding the bacterium for up to 10 years (<link linkend="ch0055s0012s0003li0019">19</link>). Carriage is frequently restricted to the gallbladder; 90% of carriers have gallstones, which serve as a surface for biofilm formation. This likely contributes to bacterial persistence and resistance to antimicrobial treatment aimed at decolonization (<link linkend="ch0055s0012s0003li0019">19</link>).</para>
      </sect2>
      <sect2 id="ch0055s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0055s0001s0004a0001"/>
        <anchor id="ch0055s0001s0004a0002"/>
        <para id="ch0055s0001s0004p0001">In healthy adults, NTS infection is a self-limited disease characterized by nonbloody diarrhea, sometimes accompanied by nausea, vomiting, and fever. Disease is typically restricted to the gastrointestinal tract and only infrequently disseminates to extraintestinal sites. Symptoms arise following a short incubation period of 6 to 72 h after ingestion of the bacterium and last 3 to 10 days (<link linkend="ch0055s0012s0003li0001">1</link>, <link linkend="ch0055s0012s0003li0014">14</link>). Rarely, asymptomatic colonization of the gallbladder can lead to chronic inflammation and may increase the risk for cholecystitis and cholelithiasis, which are risk factors leading to adenocarcinoma of the gallbladder (<link linkend="ch0055s0012s0003li0018">18</link>, <link linkend="ch0055s0012s0003li0019">19</link>). Reduced stomach acidity in infants and individuals taking antacids or proton pump inhibitors increases susceptibility to infection (<link linkend="ch0055s0012s0003li0001">1</link>). Individuals with HIV infection, asplenia, diabetes, and iatrogenic immunosuppression and the elderly have a 20-times-higher risk for infection than the general public (<link linkend="ch0055s0012s0003li0001">1</link>, <link linkend="ch0055s0012s0003li0014">14</link>, <link linkend="ch0055s0012s0003li0020">20</link>). Bloodstream infection (BSI) complicates &lt;5% of all NTS gastrointestinal infections. Patients with solid tumors, diabetes, AIDS, or hematologic malignancies account for &gt;60% of BSIs due to NTS; however, young children and the elderly are also at elevated risk (<link linkend="ch0055s0012s0003li0021">21</link>). In adults &gt;50 years of age, approximately 25 to 35% of BSIs due to NTS result in endocarditis (<link linkend="ch0055s0012s0003li0001">1</link>). Univariate analysis demonstrates that an age of &gt;65 and immunosuppression are statistically associated with increased mortality (29 to 35% mortality; odds ratio [OR], 5.8 to 6.8) following NTS bacteremia (<link linkend="ch0055s0012s0003li0021">21</link>). Importantly, &lt;10% of patients with NTS bacteremia have a history of gastroenteritis (<link linkend="ch0055s0012s0003li0022">22</link>). Therefore, lack of diarrhea should not rule out suspicion for <emphasis>Salmonella</emphasis> bacteremia, especially in an immunocompromised patient population. Immunocompromised populations are also at risk for extraintestinal infections, such as meningitis, osteomyelitis, pneumonia, and septic arthritis (<link linkend="ch0055s0012s0003li0014">14</link>). In a pediatric population, those with an immunosuppressive condition had a 25 to 30% incidence of extraintestinal infection secondary to BSI, compared to &lt;4% incidence in immunocompetent children (<link linkend="ch0055s0012s0003li0001">1</link>). In adult immunocompromised patients, 15 to 20% develop metastatic focal infections, with an associated 16% mortality (<link linkend="ch0055s0012s0003li0001">1</link>).</para>
        <para id="ch0055s0001s0004p0002">Typhoid fever and paratyphoid fever are systemic infections caused by<emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Paratyphi A, B, and C, respectively. The associated systemic infections are clinically indistinguishable and are all referred to as enteric fever. Unlike NTS disease, enteric fever has an indolent onset and is characterized by low-level bacteremia (~1 CFU/ml) and seeding of extraintestinal sites, including the liver, spleen, bone marrow, and gallbladder (<link linkend="ch0055s0012s0003li0023">23</link>). The incubation period after ingestion of the bacterium is typically 7 to 14 days, and initial symptoms are nonspecific, including low-grade fever, headache, cough, myalgia, and general malaise (<link linkend="ch0055s0012s0003li0023">23</link>). Nausea and abdominal discomfort may be present, but diarrhea is uncommon in immunocompetent individuals. If left untreated, symptoms progress to include high-grade fever with development of a maculopapular rash on the abdomen, arms, and legs in up to 30% of cases (<link linkend="ch0055s0012s0003li0023">23</link>). Patients with prolonged untreated infection (&gt;2 weeks) are at risk for more severe complications, including gastrointestinal hemorrhage or perforation, hepatitis, myocarditis, delirium, meningitis, pneumonia, disseminated intravascular coagulation, and septic shock. The hospitalization rate for patients with enteric fever is &gt;60% in the United States; however, in developing countries where enteric fever is endemic, 60 to 90% of infections are unreported or managed with empiric antibiotic treatment in outpatient settings (<link linkend="ch0055s0012s0003li0015">15</link>, <link linkend="ch0055s0012s0003li0023">23</link>). When the disease is left untreated, the overall case fatality rate is &lt;1% but can reach 30 to 50% in patients hospitalized with severe disease who do not receive appropriate antibiotic therapy (<link linkend="ch0055s0012s0003li0023">23</link>). Relapse with a milder clinical course is observed in 5 to 10% of patients within a month of symptom resolution.</para>
        <para id="ch0055s0001s0004p0003">The pathogenesis of<emphasis>Salmonella</emphasis> is driven by the ability to actively invade and replicate within gastric epithelial cells and evade clearance by phagocytes. Chromosomally encoded effectors (e.g., those encoded by <emphasis>sipA, sipC, sopE</emphasis>, and <emphasis>sptP</emphasis>) act in concert to modulate the host cell actin cytoskeleton and induce phagocytosis of the bacterium through a process known as membrane ruffling (<link linkend="ch0055s0012s0003li0024">24</link>). This is a rapid process that occurs within 10 to 15 min of bacterial contact with epithelial cells and does not cause cellular lesions or death (<link linkend="ch0055s0012s0003li0024">24</link>, <link linkend="ch0055s0012s0003li0025">25</link>). Additional effectors stimulate fluid loss and expression of inflammatory cytokines, resulting in an influx of macrophages and neutrophils and watery diarrhea.</para>
        <para id="ch0055s0001s0004p0004"><emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Paratyphi can cause systemic infection (i.e., enteric fever). An understanding of the genetic mechanisms underlying this pathogenesis is hampered by the lack of an animal model; therefore, current knowledge is based primarily on experiments using <emphasis>S.</emphasis> Typhimurium, which causes a typhoid fever-like illness in mice. Based on comparative genomic studies, <emphasis>S.</emphasis> Typhi encodes a unique surface-expressed protein known as Vi antigen (<emphasis>viaB</emphasis>) and a multimeric “typhoid” cytotoxin that are absent from NTS (<link linkend="ch0055s0012s0003li0025">25</link>). Expression of Vi antigen prevents complement-mediated killing, while cytotoxins encoded by <emphasis>pltA, cdtB</emphasis>, and <emphasis>pltC</emphasis> target host DNA to suppress the inflammatory response (<link linkend="ch0055s0012s0003li0025">25</link>, <link linkend="ch0055s0012s0003li0026">26</link>). Combined, this immune suppression and cytotoxic activity may contribute to the indolent course, dissemination, persistence, and relapse observed in patients with enteric fever.</para>
        <anchor id="ch0055s0001s0004a0003"/>
        <beginpage pagenum="749"/>
      </sect2>
      <sect2 id="ch0055s0001s0005">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0055s0001s0005a0001"/>
        <anchor id="ch0055s0001s0005a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0055s0002">
      <title>Optimal Specimen</title>
      <anchor id="ch0055s0002a0001"/>
      <anchor id="ch0055s0002a0002"/>
      <para id="ch0055s0002p0001">Detailed methods for the collection, transport, and storage of enteric pathogens are described in<ulink url="ch0035#ch0035s0001">chapter 19</ulink>. Specifically regarding isolation of <emphasis>Salmonella</emphasis> for gastroenteritis, fresh stool specimens are the preferred sample and should be cultured within 2 h of collection or transferred into a nonnutritive buffered transport medium (see “Transport and Storage” for details regarding transport media) and stored at 4°C to preserve the viability of bacteria in the specimen (<link linkend="ch0055s0012s0003li0027">27</link>). Collection of stool does not strictly require the use of sterile containers, but the specimen should not be contaminated with toilet water or urine, as these sources could introduce contamination into the specimen. For children in diapers, commercial collection devices are available, but a common collection method is to line diapers with plastic wrap or to use nonabsorbent diapers. The use of a plastic barrier will prevent the stool specimen from soaking into the diaper. An alternative is to test rectal swabs; however, swabs are less sensitive than stool for culture, with a reported 64% sensitivity (<link linkend="ch0055s0012s0003li0028">28</link>). Although fecal specimens should be prioritized when performing culture, <emphasis>Salmonella</emphasis> molecular testing demonstrates similar sensitivities with stool and rectal swabs (<link linkend="ch0055s0012s0003li0029">29</link>–<link linkend="ch0055s0012s0003li0031">31</link>). If such specimens are accepted, the laboratory should verify visible soiling of swabs as a measure of quality specimen sampling.</para>
      <para id="ch0055s0002p0002">Aside from sample type and transport vessel, the timing of specimen collection and number of specimens collected can affect the sensitivity of testing. Collection of a single stool specimen during the acute phase of infection recovers the etiological agent of community-acquired diarrhea in 94 to 98% of cases (<link linkend="ch0055s0012s0003li0032">32</link>–<link linkend="ch0055s0012s0003li0034">34</link>). When culture is negative, additional fecal specimens can be tested, but they should be collected on separate days (<link linkend="ch0055s0012s0003li0027">27</link>). Current guidelines state that up to three stools may be required to completely rule out bacterial infections using culture (<link linkend="ch0055s0012s0003li0032">32</link>, <link linkend="ch0055s0012s0003li0034">34</link>). Stool specimens for <emphasis>Salmonella</emphasis> testing should not be routinely submitted from inpatients hospitalized for &gt;3 days, as studies with both culture and molecular testing have shown that almost no <emphasis>Salmonella</emphasis> spp. are recovered/identified from these patients (<link linkend="ch0055s0012s0003li0035">35</link>, <link linkend="ch0055s0012s0003li0036">36</link>). For children, this may be extended to 4 days. In applying these rules to inpatients, consideration should be given to the potential for visitors to bring in food prepared outside the health care environment. The effects of testing multiple stools with molecular assays have not yet been evaluated. As molecular assays can be more sensitive than culture, the utility of testing additional specimens from the same patient will likely be limited and not cost effective. Molecular assays should also not be used for test of cure (<link linkend="ch0055s0012s0003li0037">37</link>).</para>
      <para id="ch0055s0002p0003">Culturing of blood, bone marrow, duodenal contents, and/or urine can be carried out when typhoid fever is suspected based on travel history and symptoms. When blood is collected for culture, a standard 40 to 60 ml of blood distributed across two or three sets is recommended (see reference<link linkend="ch0055s0012s0003li0004">4</link> for further information); due to the low bacterial burden in <emphasis>S.</emphasis> Typhi infections, it is especially important to ensure that an adequate volume of blood is submitted when <emphasis>S.</emphasis> Typhi is suspected (<link linkend="ch0055s0012s0003li0023">23</link>). Blood cultures are positive in 40 to 70% of cases, with highest rates observed in the first week of illness (<link linkend="ch0055s0012s0003li0038">38</link>, <link linkend="ch0055s0012s0003li0039">39</link>). Bone marrow and duodenal cultures of samples from adults demonstrate the highest sensitivity for culture of <emphasis>S.</emphasis> Typhi, but these specimens are rarely submitted due to their invasive collection requirements. These cultures reach 80 to 90% positivity in confirmed typhoid cases, regardless of antibiotic treatment (<link linkend="ch0055s0012s0003li0038">38</link>, <link linkend="ch0055s0012s0003li0039">39</link>). In pediatric patients, duodenal contents offer little value in children 2 to 6 years old (<link linkend="ch0055s0012s0003li0040">40</link>). Stool cultures should not be relied upon for diagnosis, as only 30% of patients with typhoid fever have organisms isolated from stool (<link linkend="ch0055s0012s0003li0023">23</link>). The impact of molecular stool testing as an aid in the diagnosis of typhoid fever has not been evaluated.</para>
    </sect1>
    <sect1 id="ch0055s0003">
      <title>Transport and Storage</title>
      <anchor id="ch0055s0003a0001"/>
      <anchor id="ch0055s0003a0002"/>
      <para id="ch0055s0003p0001">Correct transport of fecal specimens is essential for obtaining quality results for stool culture. To minimize loss of bacterial viability, testing should be performed within the first 2 h of collection for raw stool. If testing will be delayed longer than this, the Centers for Disease Control and Prevention (CDC) recommends that raw stool cultures be stored frozen at less than −15°C and rectal swabs be frozen at −70°C until testing is possible; however, it is more practical to inoculate stools into a transport medium to stabilize microbial populations, allowing storage for up to 2 to 3 days at room temperature prior to testing. Regarding molecular testing, transport and storage of stool specimens follow guidelines like those for bacterial culture. For details on differences in transport media and their stability for stool pathogens, see<ulink url="ch0056#ch0056s0001">chapter 39</ulink> (<emphasis>Escherichia and Shigella)</emphasis>.</para>
      <sect2 id="ch0055s0003s0001">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0055s0003s0001a0001"/>
        <anchor id="ch0055s0003s0001a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0055s0004">
      <title>Microscopy</title>
      <anchor id="ch0055s0004a0001"/>
      <anchor id="ch0055s0004a0002"/>
      <para id="ch0055s0004p0001">On Gram stain,<emphasis>Salmonella</emphasis> spp. are small Gram-negative rod-shaped bacteria. They are indistinguishable from other Gram-negative rods, such as other <emphasis>Enterobacterales.</emphasis> As such, direct examination of stool for presence of <emphasis>Salmonella</emphasis> with a Gram stain has no clinical utility, as <emphasis>Salmonella</emphasis> spp. cannot be distinguished from normal microbiota in the sample.</para>
      <sect2 id="ch0055s0004s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0055s0004s0001a0001"/>
        <anchor id="ch0055s0004s0001a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0055s0005">
      <title>Specimen Enrichment for Stool Culture</title>
      <anchor id="ch0055s0005a0001"/>
      <anchor id="ch0055s0005a0002"/>
      <para id="ch0055s0005p0001">Enrichment of stool cultures for isolation of<emphasis>Salmonella</emphasis> spp. can increase sensitivity of culture, as these infections are caused by low numbers of bacteria. Various enrichment broths are available, including selenite broth (SB), Rappaport-Vassiliadis (RV) broth, buffered peptone water (BPW), Gram-negative (GN) broth, and MAC broth, with GN broth and SB being the most commonly used (<link linkend="ch0055s0012s0003li0027">27</link>). These broths are selective, inhibiting growth of Gram-positive organisms as well as many Gram-negative organisms, including <emphasis>E. coli</emphasis> (<link linkend="ch0055s0012s0003li0041">41</link>). Most broths are held at 35 ± 2°C in 5% CO<subscript>2</subscript>, but this can vary with the length of incubation. For example, GN broth should be incubated for only 6 to 8 h (otherwise, normal microbiota can begin to overgrow these pathogens), whereas SB is held for 18 to 24 h (<link linkend="ch0055s0012s0003li0041">41</link>, <link linkend="ch0055s0012s0003li0042">42</link>). After incubation, broths need to be plated to solid media for full identification. Due to the delay in turnaround time, not all laboratories perform enrichment culture of <emphasis>Salmo</emphasis><emphasis>nella</emphasis> spp.</para>
      <para id="ch0055s0005p0002">A comparison of the use of SB, RV broth, and BPW to direct culture was performed on 1,096 stools, and all three broths increased isolation of<emphasis>Salmonella</emphasis> spp. (<link linkend="ch0055s0012s0003li0043">43</link>). Direct plating yielded 102 <emphasis>Salmonella</emphasis>-positive stools, whereas SB enrichment yielded 177, RV broth yielded 197, and BPW yielded 180 positive stools. Other reports show similar increases, with one identifying an additional 26 isolates from 3,977 stools using SB enrichment (<link linkend="ch0055s0012s0003li0043">43</link>). RV broth can inhibit growth of <emphasis>S.</emphasis> Typhi, which is why SB or GN broth is more commonly used. Molecular testing of stools is becoming more prevalent, and, similar to culture, broth enrichment can improve detection. One study evaluating 114 PCR-positive <emphasis>S. enterica</emphasis>-positive stools reanalyzed testing with and without SB incubation (12 to 16 h) (<link linkend="ch0055s0012s0003li0044">44</link>). In that study, the authors found that without SB incubation, PCR testing of stools missed 13% of positive stools.</para>
      <anchor id="ch0055s0005a0003"/>
      <beginpage pagenum="750"/>
    </sect1>
    <sect1 id="ch0055s0006">
      <title>General Medium Growth Requirements</title>
      <anchor id="ch0055s0006a0001"/>
      <anchor id="ch0055s0006a0002"/>
      <para id="ch0055s0006p0001">Isolation and identification of<emphasis>Salmonella</emphasis> spp. from normal fecal microbiota require several selective media to increase sensitivity. As this testing is done in parallel for other stool pathogens, minimally four media should be used, including MAC agar, a selective agar for isolation of <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis>, a selective agar for recovery of STEC O157, and a selective agar for <emphasis>Campylobacter</emphasis> (discussed in <ulink url="ch0076#ch0076s0001">chapter 59</ulink>) (<link linkend="ch0055s0012s0003li0027">27</link>, <link linkend="ch0055s0012s0003li0032">32</link>). Details specific to these stool pathogen culture methods can be found in <ulink url="ch0056#ch0056s0001">chapter 39</ulink>. Many media for <emphasis>Salmonella</emphasis> isolation overlap those for <emphasis>Shigella</emphasis> spp.; lists of common media and images of <emphasis>Salmonella</emphasis> growth are found in <anchor id="ch0055s0006a0003"/><link linkend="ch0055s0006a0004">Table 5</link> and Fig. 2, respectively, of <ulink url="ch0056#ch0056s0001">chapter 39</ulink>. Standard incubation conditions are required for growth of these organisms (excluding <emphasis>Campylobacter</emphasis> spp.), including incubation at 35 ± 2°C for 18 to 48 h. When <emphasis>Salmonella</emphasis> spp. are grown from nonstool specimens, including urine, cerebrospinal fluid, and sterile fluids, blood agar and MAC agar plates should be used for isolation.</para>
      <table id="ch0055s0006t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0055s0006a0004"/><link linkend="ch0055s0006a0003">TABLE 5</link></phrase></emphasis> Partial listing of common media for isolation of <emphasis>Escherichia, Salmonella</emphasis>, and <emphasis>Shigella</emphasis><superscript><emphasis><anchor id="ch0055s0006a0005"/><link linkend="ch0055s0006a0007">a</link></emphasis></superscript>
</title>
        
        <tgroup cols="5">
          <tbody>
            <row>
              <entry><phrase role="center">Medium</phrase>
              </entry>
              <entry><phrase role="center">Use</phrase>
              </entry>
              <entry><phrase role="center">Growth characteristics</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="center">
                  <emphasis>E. coli</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>Salmonella</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>Shigella</emphasis>
                </phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">GN broth</phrase>
              </entry>
              <entry><phrase role="left">Selective enrichment of GN rods. Most often used for STEC EIA</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Selenite broth</phrase>
              </entry>
              <entry><phrase role="left">Selective enrichment for <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis></phrase>
              </entry>
              <entry><phrase role="left">Partial to no growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">MAC broth</phrase>
              </entry>
              <entry><phrase role="left">Selective enrichment of GN rods. Most often used for STEC EIA</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
              <entry><phrase role="left">Turbid growth</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Agar</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Xylose-lysine-deoxycholate (XLD)</phrase>
              </entry>
              <entry><phrase role="left">Selective medium for isolation of <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis></phrase>
              </entry>
              <entry><phrase role="left">Small, yellowish, and may have a bile precipitate</phrase>
              </entry>
              <entry><phrase role="left">Red with black centers</phrase>
              </entry>
              <entry><phrase role="left">Red</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Hektoen enteric (HE)</phrase>
              </entry>
              <entry><phrase role="left">Selective medium for isolation of <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis></phrase>
              </entry>
              <entry><phrase role="left">Small, salmon-orange, and may have bile precipitate</phrase>
              </entry>
              <entry><phrase role="left">Greenish blue with black centers</phrase>
              </entry>
              <entry><phrase role="left">Greenish blue</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Salmonella-Shigella agar (SS)</phrase>
              </entry>
              <entry><phrase role="left">Selective medium for isolation of <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis></phrase>
              </entry>
              <entry><phrase role="left">Small, pink to red</phrase>
              </entry>
              <entry><phrase role="left">Colorless with black centers</phrase>
              </entry>
              <entry><phrase role="left">Colorless</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">MacConkey (MAC)</phrase>
              </entry>
              <entry><phrase role="left">Selective agar for GN rods</phrase>
              </entry>
              <entry><phrase role="left">Pink</phrase>
              </entry>
              <entry><phrase role="left">Colorless</phrase>
              </entry>
              <entry><phrase role="left">Colorless</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Sorbitol MacConkey (SMAC)</phrase>
              </entry>
              <entry><phrase role="left">Selective agar for identifying possible O157 isolates</phrase>
              </entry>
              <entry><phrase role="left">O157 colorless (mostly), pink-red</phrase>
              </entry>
              <entry><phrase role="left">Pink-red</phrase>
              </entry>
              <entry><phrase role="left">Variable</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">CHROMagar STEC</phrase>
              </entry>
              <entry><phrase role="left">Selective chromogenic agar for <emphasis>stx1</emphasis>- or <emphasis>stx2</emphasis>-producing organisms</phrase>
              </entry>
              <entry><phrase role="left">Mauve</phrase>
              </entry>
              <entry><phrase role="left">Blue-colorless<superscript><emphasis><anchor id="ch0055s0006a0006"/><link linkend="ch0055s0006a0008">b</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="left">Blue-colorless<superscript><emphasis><link linkend="ch0055s0006a0008">b</link></emphasis></superscript></phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">CHROMagar O157</phrase>
              </entry>
              <entry><phrase role="left">Selective chromogenic agar for O157 isolates</phrase>
              </entry>
              <entry><phrase role="left">Mauve</phrase>
              </entry>
              <entry><phrase role="left">Blue-colorless<superscript><emphasis><link linkend="ch0055s0006a0008">b</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="left">Blue-colorless<superscript><emphasis><link linkend="ch0055s0006a0008">b</link></emphasis></superscript></phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0006a0007"/><link linkend="ch0055s0006a0005">a</link></emphasis></superscript>GN, Gram-negative.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0006a0008"/><link linkend="ch0055s0006a0006">b</link></emphasis></superscript>Not specified by package insert.</para>
    </sect1>
    <sect1 id="ch0055s0007">
      <title>Plating Media for Salmonella spp.</title>
      <anchor id="ch0055s0007a0001"/>
      <anchor id="ch0055s0007a0002"/>
      <para id="ch0055s0007p0001">Several selective media can be used for the isolation of<emphasis>Salmonella</emphasis> from stool cultures. Common media include Hektoen enteric (HE) agar, Salmonella-Shigella (SS) agar, and xylose-lysine-deoxycholate (XLD) agar; examples of <emphasis>Salmonella</emphasis> growth on HE and XLD are shown in Fig. 2 of <ulink url="ch0056#ch0056s0001">chapter 39</ulink>. HE agar is a selective agar based on bile salts that reduce growth of Gram-positive organisms. This agar also contains increased amounts of peptone (12 g versus 3 g in MAC agar) with bromothymol blue and acid fuchsin (acid base indicators) and two H<subscript>2</subscript>S indicators. The increase in peptone counteracts inhibitory effects of bile salts and indicators (<link linkend="ch0055s0012s0003li0045">45</link>). <emphasis>Salmonella</emphasis> colonies are green to blue-green and can contain a black center due to production of H<subscript>2</subscript>S of some strains. <emphasis>Proteus</emphasis> and <emphasis>Shigella</emphasis> spp. can appear similar in growth to <emphasis>Salmonella</emphasis> spp., so confirmation of the identification is required. SS agar is similar in composition presumptive to HE agar and allows detection of <emphasis>Salmonella</emphasis> and <emphasis>Shigella</emphasis> spp. Detection is based on fermentation of lactose (agar turns red), and <emphasis>Salmonella</emphasis> spp., a lactose nonfermenter, will appear translucent. <emphasis>Salmonella</emphasis> organisms that produce H<subscript>2</subscript>S can quickly be identified, as these colonies have a black spot in the center of the colony when growing on SS agar. Non-H<subscript>2</subscript>S-producing <emphasis>Salmonella</emphasis> spp. can appear similar to other nonfermenters, such as <emphasis>Shigella</emphasis>, and should be followed up with confirmatory testing. <emphasis>Proteus</emphasis> spp. and Gram-positive bacteria are often inhibited in SS agar as it has increased amounts of peptone relative to MAC (<link linkend="ch0055s0012s0003li0045">45</link>). The agar also contains sodium thiosulfate and ferric citrate to allow detection of H<subscript>2</subscript>S produced by <emphasis>Salmonella</emphasis> spp. SS agar is highly selective and can inhibit growth of some <emphasis>Shigella</emphasis> spp. XLD agar uses both xylose and lysine for fermentation reactions. Lysine decarboxylation from <emphasis>Salmonella</emphasis> spp. will convert the agar to an alkaline detection (<link linkend="ch0055s0012s0003li0045">45</link>). The agar also contains sodium thiosulfate and ferric ammonium citrate to detect H<subscript>2</subscript>S production. With these formulations, <emphasis>Salmonella</emphasis> spp. will appear red on XLD agar with a black center for H<subscript>2</subscript>S-producing <emphasis>Salmonella</emphasis> spp. Of note <emphasis>Shigella</emphasis> spp. will also appear red, so non-H<subscript>2</subscript>S-producing <emphasis>Salmonella need further ident</emphasis><emphasis>ification</emphasis>.</para>
      <para id="ch0055s0007p0002">Evaluations comparing the ability of these agars to isolate<emphasis>Salmonella</emphasis> from stools have been performed. One study tested 1,597 stool specimens using both direct and enrichment plating. Specimens were enriched with either GN broth or Selenite-F broth and then plated to XLD, HE, or SS agar. Enrichment almost doubled <emphasis>Salmonella</emphasis> isolation. Parallel plating found that XLD detected the most isolates of <emphasis>Salmonella</emphasis> spp. (83%), followed by HE agar (80%) and SS agar (74% of <emphasis>Salmonella</emphasis> spp.) (<link linkend="ch0055s0012s0003li0046">46</link>). The authors also observed that HE and SS agar yielded twice the number of false-positive colonies compared to XLD agar.</para>
      <para id="ch0055s0007p0003">To improve isolation, many manufacturers have developed chromogenic agar for<emphasis>Salmonella</emphasis> isolation. A variety of manufacturers make chromogenic agar for detection of <emphasis>Salmonella</emphasis> spp. from stool. Examples of currently marketed chromogenic agar are RAPID′<emphasis>Salmonella</emphasis> medium (Bio-Rad, Hercules, CA), BBL CHROMagar <emphasis>Salmonella</emphasis> (BD Diagnostics, Sparks, MD), <emphasis>Salmonella</emphasis> ChromoSelect agar (Millipore, Burlington, MA), and Oxoid <emphasis>Salmonella</emphasis> chromogenic medium (Oxoid, Basingstoke, UK). As these agars use different chromogens, it is important to reference their instructions for use to determine colony color for detection and limitations. One study compared three chromogenic agars to plating on standard media (XLD, SS, and HE) (<link linkend="ch0055s0012s0003li0047">47</link>). Testing of 1,339 stools showed that 32 <emphasis>Salmonella</emphasis> isolates were identified on at least one medium. The chromogenic agars evaluated ranged in sensitivity from 78 to 88% after 48 h of incubation. Even when compared to chromogenic agar, XLD was the most sensitive medium used in the study, at 97% (<link linkend="ch0055s0012s0003li0047">47</link>). The authors suggest that use of enriched stools plated on BBL CHROMagar <emphasis>Salmonella</emphasis> and XLD is optimal, as 100% of <emphasis>Salmonella</emphasis> isolates were detected using this combination.</para>
      <sect2 id="ch0055s0007s0001">
        <title>IDENTIFICATION</title>
        <anchor id="ch0055s0007s0001a0001"/>
        <anchor id="ch0055s0007s0001a0002"/>
        <para id="ch0055s0007s0001p0001"><emphasis>Salmonella</emphasis> colonies are nondescript, resembling those of other members of the <emphasis>Enterobacterales</emphasis>, appearing as large white colonies that can be opaque or translucent. <emphasis>Salmonella</emphasis> spp. are nonhemolytic on blood agar (see Fig. 2 of <ulink url="ch0056#ch0056s0001">chapter 39</ulink> for characteristic growth), except for <emphasis>S.</emphasis> Abortusequi and <emphasis>S.</emphasis> Gallinarum, which can be weakly hemolytic (<link linkend="ch0055s0012s0003li0048">48</link>). <emphasis>Salmonella</emphasis> isolates are colorless on MAC agar, and all but <emphasis>S.</emphasis> Paratyphi are positive for H<subscript>2</subscript>S production. <emphasis>Salmonella</emphasis> isolates are oxidase negative and catalase positive (<link linkend="ch0055s0012s0003li0049">49</link>). On triple sugar iron agar, <emphasis>Salmonella</emphasis> is K/A with or without gas production, depending on the strain (<anchor id="ch0055s0007s0001a0003"/><link linkend="ch0055s0007s0001a0005">Fig. 1</link>). Species and subspecies can be identified by biochemicals found in <link linkend="ch0055s0001s0002a0004">Tables 1</link> and <anchor id="ch0055s0007s0001a0004"/><link linkend="ch0055s0007s0001a0006">2</link>. Important biochemical properties to differentiate <emphasis>Salmonella</emphasis> serotypes are gas production in triple sugar iron (<emphasis>S.</emphasis> Typhi is negative) and ornithine decarboxylase, which is negative for <emphasis>S.</emphasis> Typhi and positive for <emphasis>S.</emphasis> Paratyphi A (<link linkend="ch0055s0012s0003li0049">49</link>); however, the genus is diverse, and atypical strains can occur, making identification difficult. Phenotypic identification is commonly combined with serotyping for confirmation.</para>
        <figure id="ch0055s0007s0001f0001"><title><phrase role="figureLabel"><anchor id="ch0055s0007s0001a0005"/><link linkend="ch0055s0007s0001a0003">FIGURE 1</link></phrase> Triple sugar iron slant examples. Slants (left to right) are <emphasis>S.</emphasis> Paratyphi, <emphasis>S.</emphasis> Typhi, <emphasis>Shigella,</emphasis> and <emphasis>E. coli.</emphasis> Black colorization in <emphasis>Salmonella</emphasis> isolates is from H<subscript>2</subscript>S production. <emphasis>S.</emphasis> Paratyphi is K/A, G, H<subscript>2</subscript>S (type A may not have H<subscript>2</subscript>S); <emphasis>S.</emphasis> Typhi is K/A, H<subscript>2</subscript>S; <emphasis>Shigella</emphasis> is K/A; <emphasis>E. coli</emphasis> is A/A, G.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0055f01.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <table id="ch0055s0007s0001t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0055s0007s0001a0006"/><link linkend="ch0055s0007s0001a0004">TABLE 2</link></phrase></emphasis> Phenotypic traits useful for differentiating <emphasis>Salmonella</emphasis> species and subspecies<superscript><emphasis><anchor id="ch0055s0007s0001a0007"/><link linkend="ch0055s0007s0001a0017">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="12">
            <tbody>
              <row>
                <entry><phrase role="center">Species or subspecies (no. of strains tested)</phrase>
                </entry>
                <entry><phrase role="center">Reaction for:</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="center">Dulcitol</phrase>
                </entry>
                <entry><phrase role="center">Lactose</phrase>
                </entry>
                <entry><phrase role="center">ONPG</phrase>
                </entry>
                <entry><phrase role="center">Salicin</phrase>
                </entry>
                <entry><phrase role="center">Sorbitol</phrase>
                </entry>
                <entry><phrase role="center">Galac-turonate</phrase>
                </entry>
                <entry><phrase role="center">Malonate</phrase>
                </entry>
                <entry><phrase role="center">Mucate</phrase>
                </entry>
                <entry><phrase role="center">Growth in KCN</phrase>
                </entry>
                <entry><phrase role="center">Gelatin (strip)</phrase>
                </entry>
                <entry><phrase role="center"><phrase role="small">L</phrase>(+)-Tartrate (<emphasis>d</emphasis>-tartrate<superscript><emphasis><anchor id="ch0055s0007s0001a0008"/><link linkend="ch0055s0007s0001a0018">b</link></emphasis></superscript>)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> I (650)</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> II (110)</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−<superscript><link linkend="ch0055s0007s0001a0019">c</link></superscript></phrase>
                  <anchor id="ch0055s0007s0001a0009"/>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> IIIa (85)</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−<superscript><emphasis><anchor id="ch0055s0007s0001a0010"/><link linkend="ch0055s0007s0001a0020">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> IIIb (155)</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−<superscript><emphasis><anchor id="ch0055s0007s0001a0011"/><link linkend="ch0055s0007s0001a0021">e</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−<superscript><emphasis><anchor id="ch0055s0007s0001a0012"/><link linkend="ch0055s0007s0001a0022">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> IV (85)</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+<superscript><emphasis><anchor id="ch0055s0007s0001a0013"/><link linkend="ch0055s0007s0001a0023">g</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. enterica</emphasis> VI (9)</phrase>
                </entry>
                <entry><phrase role="center">d<superscript><emphasis><anchor id="ch0055s0007s0001a0014"/><link linkend="ch0055s0007s0001a0024">h</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">d<superscript><emphasis><anchor id="ch0055s0007s0001a0015"/><link linkend="ch0055s0007s0001a0025">i</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">d<superscript><emphasis><anchor id="ch0055s0007s0001a0016"/><link linkend="ch0055s0007s0001a0026">j</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>S. bongori</emphasis> (16)</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">+</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
                <entry><phrase role="center">−</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0017"/><link linkend="ch0055s0007s0001a0007">a</link></emphasis></superscript>Reactions after incubation at 37°C. Abbreviations and symbols: +, 90% (or more) of strains were positive within 1 or 2 days; (+), positive reaction after 3 or more days; −, no reaction (90% or more) in 7 days; d, different reactions [+, (+), −]; ONPG, <emphasis>o</emphasis>-nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside. (Adapted with permission from reference <link linkend="ch0055s0012s0003li0112">112</link>.)</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0018"/><link linkend="ch0055s0007s0001a0008">b</link></emphasis></superscript>Sodium potassium tartrate (<link linkend="ch0055s0012s0003li0112">112</link>).</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0019"/><link linkend="ch0055s0007s0001a0009">c</link></emphasis></superscript>A total of 15% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0020"/><link linkend="ch0055s0007s0001a0010">d</link></emphasis></superscript>A total of 15% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0021"/><link linkend="ch0055s0007s0001a0011">e</link></emphasis></superscript>A total of 85% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0022"/><link linkend="ch0055s0007s0001a0012">f</link></emphasis></superscript>A total of 30% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0023"/><link linkend="ch0055s0007s0001a0013">g</link></emphasis></superscript>A total of 60% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0024"/><link linkend="ch0055s0007s0001a0014">h</link></emphasis></superscript>A total of 67% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0025"/><link linkend="ch0055s0007s0001a0015">i</link></emphasis></superscript>A total of 22% were positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0055s0007s0001a0026"/><link linkend="ch0055s0007s0001a0016">j</link></emphasis></superscript>A total of 44% were positive.</para>
        <para id="ch0055s0007s0001p0002">Rapid phenotypic assays such as VITEK 2, MicroScan, and BD Phoenix can be used for identification, but they have been found to have some issues, likely due to strain diversity. Studies by O’Hara (<link linkend="ch0055s0012s0003li0052">52</link>) and by O’Hara and Miller (<link linkend="ch0055s0012s0003li0050">50</link>, <link linkend="ch0055s0012s0003li0051">51</link>) evaluated various enteric isolates for overall performance of detecting common stool pathogens. In the O’Hara study (<link linkend="ch0055s0012s0003li0050">50</link>), <emphasis>t</emphasis>esting with VITEK 2 found that four lactose-positive <emphasis>Salmonella</emphasis> strains were reported as <emphasis>E. coli</emphasis> with a “very good” confidence value (<link linkend="ch0055s0012s0003li0050">50</link>). Using MicroScan, there were five misidentifications, with four being reported with &gt;90% probability as either <emphasis>E. coli, Shigella,</emphasis> or <emphasis>Leminorella</emphasis> spp. (<link linkend="ch0055s0012s0003li0051">51</link>). A total of seven misidentifications were observed with Phoenix, which also included an additional 18 fresh isolates (non-CDC library). Six were reported as <emphasis>E. coli</emphasis> and one as <emphasis>Shigella sonnei</emphasis> (<link linkend="ch0055s0012s0003li0052">52</link>). Overall, the sensitivity of these systems is high, but due to variability of biochemical reactions when isolates are recovered from stool, follow-up biochemical testing should be performed to confirm identification. Furthermore, isolates of <emphasis>Salmonella</emphasis> spp. should be sent to a public health facility for typing.</para>
        <anchor id="ch0055s0007s0001a0027"/>
        <beginpage pagenum="751"/>
        <para id="ch0055s0007s0001p0003">Two matrix-assisted laser desorption ionization–time-of-flight mass spectrometry systems (MALDI-TOF MS), the VITEK MS (BioMérieux, Durham, NC) and MALDI Biotyper (Bruker Daltonics Inc., Billerica, MA), have become standard practice for many laboratories for identification of isolates. Both have FDA-cleared and research-use-only (RUO) libraries that include<emphasis>Salmonella.</emphasis> Overall, <emphasis>Salmonella</emphasis> spp. are accurately identified to the genus level (<link linkend="ch0055s0012s0003li0053">53</link>, <link linkend="ch0055s0012s0003li0054">54</link>). The current Bruker Biotyper libraries cannot readily differentiate serotypes, so it is recommended that follow-up serotyping be performed when required for patient care. Possible future updates to libraries may differentiate serotypes by measuring specific <emphasis>m</emphasis>/<emphasis>z</emphasis> peaks; however, these applications are still in the research phase (<link linkend="ch0055s0012s0003li0055">55</link>, <link linkend="ch0055s0012s0003li0056">56</link>). The VITEK MS database does allow differentiation of <emphasis>Salmonella</emphasis> spp., and in one study, it correctly identified three of five typhoidal serovars tested, although the manufacturer recommends additional serovar testing for confirmation (<link linkend="ch0055s0012s0003li0057">57</link>). Both instruments require RUO libraries for identification of <emphasis>S</emphasis><emphasis>. bongori</emphasis>.</para>
        <anchor id="ch0055s0007s0001a0028"/>
        <beginpage pagenum="752"/>
      </sect2>
    </sect1>
    <sect1 id="ch0055s0008">
      <title>Nucleic Acid Amplification Testing of Stool</title>
      <anchor id="ch0055s0008a0001"/>
      <anchor id="ch0055s0008a0002"/>
      <para id="ch0055s0008p0001">Nucleic acid amplification testing (NAAT) methods have been applied to the identification of<emphasis>Salmonella</emphasis> spp., and are often paired to detect multiple other bacterial, viral, and protozoan agents associated with acute gastroenteritis. Several FDA-cleared multiplexed molecular panels have been developed that can detect 3 to 22 individual targets (see <anchor id="ch0055s0008a0003"/><ulink url="ch0056#ch0056s0020a0004">Table 7</ulink> in <ulink url="ch0056#ch0056s0001">chapter 39</ulink>). Narrow or focused panels often identify <emphasis>Salmonella, Shigella, Campylobacter</emphasis> spp. and genes encoding Shiga toxins (<emphasis>stx1</emphasis> and <emphasis>stx2</emphasis>), while broad panels include multiple additional bacterial, viral, and protozoan pathogens. These panels range from high-complexity tests requiring off-line extraction and manual setup of individual real-time PCRs to moderate-complexity sample-to-result platforms capable of generating a result in approximately 1 h.</para>
      <para id="ch0055s0008p0002">Results from clinical trial and research studies have demonstrated excellent performance for the detection of<emphasis>Salmonella</emphasis> spp., with reported sensitivities ranging from 82.7 to 100% in preserved stool specimens (<link linkend="ch0055s0012s0003li0058">58</link>–<link linkend="ch0055s0012s0003li0061">61</link>). Furthermore, sensitivity appears to be higher than conventional culture and broth-enriched enzyme immunoassay (EIA) methods. In one study, there were an additional 19 positives compared to culture, which was a 66% increase in positive detections (<link linkend="ch0055s0012s0003li0062">62</link>). The increased rate of detection is directly related to a 1- to 2-log<subscript>10</subscript> difference in limit of detection between culture and NAAT. Using an FDA-cleared NAAT, Anderson et al. (<link linkend="ch0055s0012s0003li0062">62</link>) reported 100% sensitivity for <emphasis>Salmonella</emphasis> spp., at a concentration of 10<superscript>5</superscript> CFU/ml and 69% sensitivity at 10<superscript>4</superscript> CFU/ml, followed by 44% at 10<superscript>3</superscript> CFU/ml in stool matrix. This contrasts with culture methods, which demonstrated 100% sensitivity at 10<superscript>6</superscript> CFU/ml, diminished upon dilution to 81, 31, and 0% per log CFU/ml (<link linkend="ch0055s0012s0003li0062">62</link>).</para>
      <para id="ch0055s0008p0003">NAAT assays also improve the turnaround for<emphasis>Salmonella</emphasis> detection. Depending on the assay and level of automation in extraction and testing, results are available in 8 h for manually batched assays or 1 h for more sample-to-answer assays. The decreased time to result has the potential to positively impact patient management and infection control efforts. Empirical antibiotic treatment is not recommended in uncomplicated cases of gastroenteritis; however, antibiotics are frequently prescribed and may be appropriate for children &lt;3 months of age, persons with severe diarrhea, or persons with systemic disease (<link linkend="ch0055s0012s0003li0063">63</link>). In these cases, a rapid, highly sensitive and specific assay could result in reducing empiric antibiotic treatment or at a minimum allow discontinuation of antibiotics that are not needed for the pathogen detected.</para>
      <para id="ch0055s0008p0004">While molecular assays are highly sensitive and significantly faster than conventional methods, laboratories need to consider the high cost of the test, as well as the associated cost to the patient or insurer and the clinical utility of rapid results. Laboratories may want to limit testing to complicated cases or inpatient testing, as there is limited information on the clinical impact of a rapid molecular result for outpatients with uncomplicated gastroenteritis. For complicated cases or severely ill patients, a molecular assay may be useful; however, at the time of writing, there are no large studies examining the impact of molecular panels on antibiotic stewardship, patient outcome, or overall cost of care. Current guidelines for diagnosis of infectious diarrhea recommend a selective and targeted approach, including testing for only<emphasis>Salmonella, Shigella, Campylobacter</emphasis>, and <emphasis>Yersinia</emphasis> spp., Shiga toxin-producing <emphasis>E. coli</emphasis> (STEC) including serotype O157, and <emphasis>Clostridioides difficile</emphasis> based on exposure, risk factors, and clinical symptoms (<link linkend="ch0055s0012s0003li0063">63</link>). Several narrow molecular panels are available that cover these pathogens and are listed in <ulink url="ch0056#ch0056s0020a0004">Table 7</ulink> of <ulink url="ch0056#ch0056s0001">chapter 39</ulink> (<link linkend="ch0055s0012s0003li0064">64</link>). Current guidelines also suggest that diagnostic testing is not routinely recommended for mild cases of acute gastroenteritis lasting &lt;7 days unless the patient is at risk for severe disease (<link linkend="ch0055s0012s0003li0063">63</link>, <link linkend="ch0055s0012s0003li0065">65</link>). For patients with persistent diarrhea (&gt;7 days), fever, leukocytosis, and history of travel; infants; and patients who are immunocompromised, a broader pathogen differential, including parasites and uncommon bacterial pathogens, may be considered (<link linkend="ch0055s0012s0003li0063">63</link>, <link linkend="ch0055s0012s0003li0065">65</link>). For these patients, use of broad-panel testing may be warranted. NAATs have also been found to be positive well after treatment and resolution of symptoms. Because NAATs are unable to differentiate between viable and nonviable organisms, they are not recommended for use as a test of cure (<link linkend="ch0055s0012s0003li0063">63</link>). When a test of cure is required for selected populations (food handlers, health care workers, and children returning to child care), a negative stool culture can be considered to support low risk of transmissibility (<link linkend="ch0055s0012s0003li0063">63</link>).</para>
      <para id="ch0055s0008p0005">A weakness of exclusive reliance on NAAT for detection of gastrointestinal pathogens is the lack of recovery of an isolate. These assays report only to genus level, potentially leading to negative impacts on public health and epidemiology efforts. Recovery of a bacterial isolate is critical to outbreak investigation and identification of emerging bacterial serotypes associated with gastroenteritis. Further, phenotypic antimicrobial susceptibility testing requires an isolate. Therefore, the ability to conduct routine bacterial culture on stool specimens should be maintained. However, if NAAT is employed as a first-line diagnostic test, culture may be selectively utilized for only those specimens that test positive or when antimicrobial susceptibility results are necessary for clinical care. Maintenance of routine culture methods is also important to support public health and surveillance goals (<link linkend="ch0055s0012s0003li0063">63</link>).</para>
    </sect1>
    <sect1 id="ch0055s0009">
      <title>NAAT and Antigen Detection from Nonstool Specimens</title>
      <anchor id="ch0055s0009a0001"/>
      <anchor id="ch0055s0009a0002"/>
      <para id="ch0055s0009p0001">The role of<emphasis>Salmonella</emphasis> infections in bloodstream infections and endocarditis has led to some assay developers adding primers and probes specific for the detection of <emphasis>Salmonella</emphasis> to their blood culture panels. Prevalence is low, and studies in Finland, Australia, Denmark, and Canada have found incidence rates of 1.02 per 100,000 population (<link linkend="ch0055s0012s0003li0066">66</link>). Prevalence can be higher in other countries, with rates as high as 100 per 100,000 population in Africa (<link linkend="ch0055s0012s0003li0067">67</link>). To date, only two panels have a <emphasis>Salmonella</emphasis> target that is FDA cleared: BioFire BCID2 (bioMerieux, Marcy l’Etoile, FR) and the GenMark ePlex BCID-GN panel (GenMark, Carlsbad, CA). In addition, due to the low prevalence, prospective studies evaluating these assays have a limited number of <emphasis>Salmonella</emphasis> cases. Clinical trial data from the BioFire BCID2 found 100% sensitivity and specificity for <emphasis>Salmonella</emphasis> spp., which was replicated in a separate study; however these data are limited, as only one prospective <emphasis>Salmonella</emphasis> specimen was tested during the evaluation (<link linkend="ch0055s0012s0003li0068">68</link>). The clinical performance reported in the package insert found 100% positive percent agreement (PPA) for detection of <emphasis>Salmonella</emphasis> spp., which included 5 prospective specimens, 16 frozen archived specimens, and 37 seeded samples (<link linkend="ch0055s0012s0003li0068">68</link>). Similar results were found for the GenMark ePlex BCID-GN panel, as the FDA submission found a PPA of 96% (discordant analysis agreed with ePlex result), and another study found 100% agreement, but with the limitation of a single positive specimen tested in the prospective trial (<link linkend="ch0055s0012s0003li0069">69</link>, <link linkend="ch0055s0012s0003li0070">70</link>). Further studies are needed to fully evaluate these assays at a clinical level, but molecular identification is likely sensitive and can be linked to detection of antimicrobial resistance genes, which coming from a nonsterile source requires follow-up phenotypic antimicrobial susceptibility testing (AST) to link resistance to the pathogen. However, these panels report only the genus, so further characterization of subcultured isolates is needed.</para>
      <anchor id="ch0055s0009a0003"/>
      <beginpage pagenum="753"/>
      <sect2 id="ch0055s0009s0001">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0055s0009s0001a0001"/>
        <anchor id="ch0055s0009s0001a0002"/>
        <para id="ch0055s0009s0001p0001">Strain typing strategies for<emphasis>Enterobacterales</emphasis>, which were previously based primarily on antigenic methods, have undergone recent and dramatic evolution with the advent of next-generation sequencing (NGS)-based approaches. The widespread adoption of NGS techniques has allowed detailed lineage studies of epidemiologically significant strains and fine-scale tracking of transmission chains in hospital, community, and foodborne outbreaks. Furthermore, development of public central tracking systems such as the FDA’s GenomeTrakr Network, in which sequenced outbreak genomes are deposited and indexed, has allowed geographic mapping of outbreak lineages in real time. In this section, we begin with traditional classification schemes based on antigenic typing, pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST) and then cover newer molecular and NGS-based approaches, including ribosomal MLST (rMLST), whole-genome and core-genome MLST (wgMLST and cgMLST), and whole-genome single-nucleotide variant (SNV)-based strain tracking.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0055s0010">
      <title>Antigenic Typing of Salmonella spp.</title>
      <anchor id="ch0055s0010a0001"/>
      <anchor id="ch0055s0010a0002"/>
      <para id="ch0055s0010p0001">Compared with other genera of<emphasis>Enterobacterales, Salmonella</emphasis> spp<emphasis>.</emphasis> display remarkable antigenic diversity. Consequently, specific methods have been developed for antigenic typing of this genus, and these are reviewed below. For a more general overview of antigenic typing methods for <emphasis>Enterobacterales,</emphasis> see <ulink url="ch0056#ch0056s0001">chapter 39</ulink><emphasis>. Salmonella</emphasis> spp. have classically been typed based on O, H, and Vi antigens, and serotypes are classified by the White-Kauffmann-Le Minor (WKL) scheme (<link linkend="ch0055s0012s0003li0071">71</link>–<link linkend="ch0055s0012s0003li0073">73</link>). This scheme defines more than 2,500 serotypes, with the majority causing disease in humans belonging to <emphasis>S. enterica</emphasis> subspecies <emphasis>enterica</emphasis> (<link linkend="ch0055s0012s0003li0074">74</link>). Typing usually begins with O antigen antisera, as O serogroup determination is sufficient to confirm isolates as belonging to the genus <emphasis>Salmonella.</emphasis> Depending on the exact approach, O antigen groups are tested successively in pools, followed by testing with individual antisera. O antigen groups were originally designated by letters, and subsequently, each O antigen has been individually numbered. Although numbers are used in the antigenic formulae of the WKL scheme, O antigen groups are still referred to by letters by many typing laboratories.</para>
      <para id="ch0055s0010p0002">Following O antigen determination, the H group is typed.<emphasis>Salmonella</emphasis> spp. are unusual among <emphasis>Enterobacterales</emphasis> in that many <emphasis>Salmonella</emphasis> serotypes encode two flagellar proteins, designated H1 and H2, referred to as phase 1 and phase 2 antigens, respectively (<link linkend="ch0055s0012s0003li0075">75</link>, <link linkend="ch0055s0012s0003li0076">76</link>), and strains that are capable of switching between the expression of two flagellar proteins are referred to as diphasic. Strains expressing only one H antigen are referred to as monophasic, with <emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Enteritidis constituting important examples. Rare nonmotile strains may not express detectable H antigen (<link linkend="ch0055s0012s0003li0074">74</link>). Different parts of flagellin proteins may be recognized separately by different antibodies in antisera used for typing, thus defining multiple H1 or H2 antigenic determinants present simultaneously for a single flagellin protein. Consequently, multiple antigenic assignments may be made to each of the H antigen group phases; these are distinguished by numbers in antigenic formulae. It is now known that in most <emphasis>Salmonella</emphasis> isolates, phase 1 H antigens are encoded by the <emphasis>fliC</emphasis> gene and phase 2 H antigens by the <emphasis>fljB</emphasis> gene (<link linkend="ch0055s0012s0003li0076">76</link>, <link linkend="ch0055s0012s0003li0077">77</link>). A third antigen used for typing of <emphasis>Salmonella</emphasis> spp. is the Vi antigen. The Vi antigen in <emphasis>Salmonella</emphasis> spp. is controlled by the <emphasis>viaA</emphasis> and <emphasis>viaB</emphasis> loci, found predominantly in typhoidal strains, although Vi is also expressed in some <emphasis>Citrobacter</emphasis> isolates (<link linkend="ch0055s0012s0003li0078">78</link>), so Vi antigen alone cannot be used for primary classification without excluding <emphasis>Citrobacter</emphasis> spp. by independent methods.</para>
      <para id="ch0055s0010p0003"><emphasis>Salmonella</emphasis> serotypes are formally named within the WKL scheme as follows: subspecies [space] O antigen(s), Vi antigen if present: phase 1 H antigen(s): phase 2 H antigens(s) if present. Serotypes belonging to subspecies I (<emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis>) are also often given a name, with more than 1,500 named serotypes (<link linkend="ch0055s0012s0003li0071">71</link>). By convention, these serotype names are capitalized and not italicized. Furthermore, many authors choose to omit the designation “subsp. <emphasis>enterica</emphasis>” when referring to the serotype by name, as other subspecies do not receive names and are referred to only with antigenic formulae. Because <emphasis>Salmonella</emphasis> strains actively exchange genetic material, novel antigenic combinations arise that are not easily classified within the WKL scheme (<link linkend="ch0055s0012s0003li0079">79</link>); molecular methods for dealing with these strains are discussed below. Two of the most common pathogenic serotypes of <emphasis>S. enterica</emphasis> subsp. <emphasis>enterica</emphasis> are the monophasic <emphasis>S.</emphasis> Enteritidis (serotype I 9,12:g,m:−) and the diphasic <emphasis>S.</emphasis> Typhimurium (serotype I 4,[5],12:i:1,2) (<link linkend="ch0055s0012s0003li0071">71</link>). Serotypes, in turn, are organized into larger serogroups. <anchor id="ch0055s0010a0003"/><link linkend="ch0055s0011a0004">Table 3</link> compares serogroups and common serotypes.</para>
    </sect1>
    <sect1 id="ch0055s0011">
      <title>Traditional Molecular Methods</title>
      <anchor id="ch0055s0011a0001"/>
      <anchor id="ch0055s0011a0002"/>
      <para id="ch0055s0011p0001">The antigenic approaches described above depend on the production and maintenance of &gt;250 antigen-specific antisera, limiting testing to a small number of public health and reference labs. For this reason, a variety of molecular methods that can be performed on instruments widely available to clinical labs without the need for specialized reagents have begun to play an increasingly important role in<emphasis>Salmonella</emphasis> classification. For a general discussion of these methods, including PFGE and MLST approaches, see <ulink url="ch0027#ch0027s0001">chapter 12</ulink>. For <emphasis>Salmonella</emphasis> spp., studies of PFGE have demonstrated 75 to 99% concordance with classical serotyping following categorization of pulsotypes, depending on the diversity of the isolate set and chosen restriction enzyme (<link linkend="ch0055s0012s0003li0074">74</link>). MLST has many advantages over PFGE testing, given the reliability of PCR, on which it is based, and the widespread familiarity with PCR instruments. MLST has been extensively compared with classical serotype classifications for <emphasis>Salmonella</emphasis> spp. and has been found to have certain advantages, although not all serotypes are distinguishable as unique sequence types in standard MLST schemes. Comparative studies performed with MLST schemes based on three, four, and seven genes demonstrate concordances with classical serotyping of 88 to 100%, depending on the scheme and isolates (<link linkend="ch0055s0012s0003li0074">74</link>, <link linkend="ch0055s0012s0003li0080">80</link>).</para>
      <anchor id="ch0055s0011a0003"/>
      <beginpage pagenum="754"/>
      <table id="ch0055s0011t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0055s0011a0004"/><link linkend="ch0055s0010a0003">TABLE 3</link></phrase></emphasis> Summary of the most common enteric-disease-causing <emphasis>Salmonella</emphasis> serotypes associated with the various serogroups in the United States (<link linkend="ch0055s0012s0003li0113">113</link>)
</title>
        
        <tgroup cols="4">
          <tbody>
            <row>
              <entry><phrase role="center">Serogroup</phrase>
              </entry>
              <entry><phrase role="center">Serotype</phrase>
              </entry>
              <entry><phrase role="center">CDC rank</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="center">2011</phrase>
              </entry>
              <entry><phrase role="center">2016</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">B</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>S.</emphasis> Typhimurium</phrase>
              </entry>
              <entry><phrase role="center">  2</phrase>
              </entry>
              <entry><phrase role="center">  3</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Paratyphi B</phrase>
              </entry>
              <entry><phrase role="center">16</phrase>
              </entry>
              <entry><phrase role="center">19</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> I 4,[5],12:i:−</phrase>
              </entry>
              <entry><phrase role="center">  5</phrase>
              </entry>
              <entry><phrase role="center">  5</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Heidelberg</phrase>
              </entry>
              <entry><phrase role="center">  7</phrase>
              </entry>
              <entry><phrase role="center">12</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Saintpaul</phrase>
              </entry>
              <entry><phrase role="center">12</phrase>
              </entry>
              <entry><phrase role="center">11</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Agona</phrase>
              </entry>
              <entry><phrase role="center">15</phrase>
              </entry>
              <entry><phrase role="center">18</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">C</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>S.</emphasis> Newport</phrase>
              </entry>
              <entry><phrase role="center">  3</phrase>
              </entry>
              <entry><phrase role="center">  2</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Infantis</phrase>
              </entry>
              <entry><phrase role="center">  9</phrase>
              </entry>
              <entry><phrase role="center">  6</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Montevideo</phrase>
              </entry>
              <entry><phrase role="center">  6</phrase>
              </entry>
              <entry><phrase role="center">  8</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Muenchen</phrase>
              </entry>
              <entry><phrase role="center">  8</phrase>
              </entry>
              <entry><phrase role="center">  7</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Braenderup</phrase>
              </entry>
              <entry><phrase role="center">10</phrase>
              </entry>
              <entry><phrase role="center">  9</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Thompson</phrase>
              </entry>
              <entry><phrase role="center">14</phrase>
              </entry>
              <entry><phrase role="center">10</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Oranienburg</phrase>
              </entry>
              <entry><phrase role="center">11</phrase>
              </entry>
              <entry><phrase role="center">13</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Bareilly</phrase>
              </entry>
              <entry><phrase role="center">17</phrase>
              </entry>
              <entry><phrase role="center">16</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">D</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>S.</emphasis> Enteritidis</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
              <entry><phrase role="center">  1</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Javiana</phrase>
              </entry>
              <entry><phrase role="center">  4</phrase>
              </entry>
              <entry><phrase role="center">  4</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Typhi</phrase>
              </entry>
              <entry><phrase role="center">18</phrase>
              </entry>
              <entry><phrase role="center">15</phrase>
              </entry>
            </row>
            <row>
              <entry/>
              <entry><phrase role="left"><emphasis>S.</emphasis> Berta</phrase>
              </entry>
              <entry><phrase role="center">19</phrase>
              </entry>
              <entry><phrase role="center">17</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">E</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>S.</emphasis> Anatum</phrase>
              </entry>
              <entry><phrase role="center">21</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">G</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>S.</emphasis> Mississippi</phrase>
              </entry>
              <entry><phrase role="center">13</phrase>
              </entry>
              <entry><phrase role="center">14</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
    </sect1>
    <sect1 id="ch0055s0012">
      <title>NGS-Based Typing</title>
      <anchor id="ch0055s0012a0001"/>
      <anchor id="ch0055s0012a0002"/>
      <para id="ch0055s0012p0001">The increasing availability of NGS instruments and large reference genome databases has made possible new approaches to bacterial strain typing. In this section, we focus on the details of selected genomic approaches for predicting<emphasis>Salmonella</emphasis> serotypes and epidemiologic investigations. For a general discussion of the application of NGS methods for bacterial typing and epidemiology, see <ulink url="ch0027#ch0027s0001">chapter 12</ulink>.</para>
      <para id="ch0055s0012p0002">The development of genomic approaches for<emphasis>Salmonella</emphasis> serotype prediction has benefited substantially from the efforts of the CDC’s PulseNet National Laboratory Network and the FDA’s GenomeTrakr, which have correlated classical serotypes, PFGE pulsotypes, and whole-genome sequencing (WGS) genotypes for a large number of isolates. Uploaded genomes from these programs may be found in the NCBI Pathogen Detection Database (<ulink url="https://www.ncbi.nlm.nih.gov/pathogens/">https://www.ncbi.nlm.nih.gov/pathogens/</ulink>), and genomic data from more than 400,000 <emphasis>Salmonella</emphasis> isolates are available. A number of stand-alone bioinformatics pipelines that take either assembled genome contigs or raw reads for input and predict a serotype have been developed, and here, we focus on two commonly used programs: <emphasis>Salmonella In Silico</emphasis> Typing Resource (SISTR) (<link linkend="ch0055s0012s0003li0081">81</link>) and SeqSero (<link linkend="ch0055s0012s0003li0082">82</link>). SISTR is an open-source program available for local installation or as a web-based tool (<ulink url="https://github.com/phac-nml/sistr_cmd">https://github.com/phac-nml/sistr_cmd</ulink>) that incorporates the <emphasis>Salmonella</emphasis> genoserotyping array method (<link linkend="ch0055s0012s0003li0083">83</link>) for serotype assignment along with rMLST and cgMLST analysis. SISTR takes as input a minimally processed draft genome and analyzes variations in the <emphasis>rfb</emphasis> gene cluster’s O-antigen flippase (<emphasis>wzx</emphasis>) and polymerase (<emphasis>wzy</emphasis>) genes and H-antigen flagellin genes, <emphasis>fliC</emphasis> and <emphasis>fljB</emphasis>, to generate a serotype prediction. Two published validations of SISTR demonstrated 94.6% and 94.8% concordance with traditional serotyping (<link linkend="ch0055s0012s0003li0081">81</link>, <link linkend="ch0055s0012s0003li0084">84</link>). SeqSero is another open-source program available for local installation (<ulink url="https://github.com/denglab/SeqSero">https://github.com/denglab/SeqSero</ulink>) or as a web-based tool (<ulink url="http://www.denglab.info/SeqSero">www.denglab.info/SeqSero</ulink>). Similar to SISTR, SeqSero performs serotyping based on the <emphasis>rfb</emphasis> gene cluster and <emphasis>fliC</emphasis> and <emphasis>fliB</emphasis> genes and can identify &gt;2,300 serotypes from both raw sequencing reads and draft assemblies. Two studies demonstrated concordance with traditional serotypes that ranged from 88.2 to 98.7% (<link linkend="ch0055s0012s0003li0082">82</link>, <link linkend="ch0055s0012s0003li0084">84</link>). It should be noted that with both genomic approaches, discrepancies occur when genes are carried by an isolate in the genome but not expressed antigenically. Some have thus suggested reframing serotyping in terms of genome composition (<link linkend="ch0055s0012s0003li0084">84</link>).</para>
      <para id="ch0055s0012p0003">For epidemiologic tracking of<emphasis>Salmonella</emphasis> spp. in outbreaks, cgMLST, wgMLST, and whole-genome SNV-based approaches have been used successfully (<link linkend="ch0055s0012s0003li0085">85</link>–<link linkend="ch0055s0012s0003li0087">87</link>). A range of similarity criteria have been used for cluster definition in published outbreak investigations, and it is important to note that any applied threshold needs to be evaluated in the context of the approach (whole genome or core genome; allele based or variant based) and the epidemiological structure of the outbreak. For whole-genome SNV-based approaches, similarity levels of 10 to 20 or fewer SNVs with clear monophyletic population structure have been viewed as generally indicative of clonal relatedness and single-source origin (<link linkend="ch0055s0012s0003li0088">88</link>, <link linkend="ch0055s0012s0003li0089">89</link>).</para>
      <sect2 id="ch0055s0012s0001">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0055s0012s0001a0001"/>
        <anchor id="ch0055s0012s0001a0002"/>
        <para id="ch0055s0012s0001p0001">Antimicrobial therapy is not recommended for uncomplicated cases of<emphasis>Salmonella</emphasis> gastroenteritis, and therefore, routine susceptibility testing of fecal isolates is not warranted for treatment purposes (<link linkend="ch0055s0012s0003li0065">65</link>). However, determination of antimicrobial susceptibility is valuable for surveillance purposes to monitor the development and spread of antimicrobial resistance among <emphasis>Salmonella</emphasis> isolates. In addition, treatment with an active antimicrobial agent is crucial for patients with invasive nontyphoidal <emphasis>Salmonella</emphasis> and typhoidal infections, and susceptibilities of these isolates should be reported as soon as possible (<link linkend="ch0055s0012s0003li0065">65</link>). Wild-type isolates of <emphasis>Salmonella</emphasis> spp. are susceptible to most antimicrobial agents, with the notable exceptions of first- and second-generation cephalosporins, cephamycin, and aminoglycosides, which may appear active <emphasis>in vitro</emphasis> but are ineffective clinically (<link linkend="ch0055s0012s0003li0090">90</link>). Traditionally, ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole were first-line therapy for serious <emphasis>Salmonella</emphasis> infections (<link linkend="ch0055s0012s0003li0091">91</link>). Resistance to these agents first evolved in <emphasis>S.</emphasis> Typhi in the late 1980s, emerging in Pakistan, India, and Southeast Asia. At this time, fluoroquinolones were the drug of choice, but resistance quickly emerged in the 1990s, leading to widespread use of expanded-spectrum cephalosporins (e.g., ceftriaxone and cefixime), macrolides (e.g., azithromycin), or carbapenems for treatment of typhoid fever (<link linkend="ch0055s0012s0003li0091">91</link>). The recent emergence of an extensively drug-resistant (XDR) <emphasis>S.</emphasis> Typhi H58 haplotype, resistant to the first-line agents chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole as well as second-line fluoroquinolones and expanded-spectrum cephalosporins, is of significant concern (<link linkend="ch0055s0012s0003li0092">92</link>). More than 10,365 infections with XDR <emphasis>S.</emphasis> Typhi were reported as of 2019 in Pakistan (<link linkend="ch0055s0012s0003li0093">93</link>), and numerous cases have been reported in Iraq (<link linkend="ch0055s0012s0003li0094">94</link>). In 2021, the CDC issued an alert regarding U.S.-acquired infections caused by this XDR strain of <emphasis>S.</emphasis> Typhi (<link linkend="ch0055s0012s0003li0095">95</link>).</para>
        <anchor id="ch0055s0012s0001a0003"/>
        <beginpage pagenum="755"/>
        <para id="ch0055s0012s0001p0002">A recent meta-analysis of the literature demonstrated that among global reports in 2015 to 2018, 37% of<emphasis>S.</emphasis> Typhi isolates were resistant to chloramphenicol, 42% to ampicillin, and 39% to trimethoprim-sulfamethoxazole (<link linkend="ch0055s0012s0003li0096">96</link>). In total, roughly one-third (33% of 5,621 tested) of isolates were multidrug resistant (MDR). Resistance to second-line agents was also common: 36% of isolates were not susceptible to ciprofloxacin, 6% were resistant to expanded-spectrum cephalosporins, and 7% were resistant to azithromycin. The rate of meropenem resistance was 3%, driven by unconfirmed reports of meropenem-resistant <emphasis>S.</emphasis> Typhi in Pakistan and Indonesia (<link linkend="ch0055s0012s0003li0096">96</link>). Phylogenetic analysis has demonstrated that the global <emphasis>S.</emphasis> Typhi population is highly clonal, which has driven this global emergence of MDR strains. In particular, the MDR <emphasis>S.</emphasis> Typhi H58 lineage, which emerged in the early 1990s and harbors an IncHI1 MDR plasmid and chromosomal mutations conferring fluoroquinolone resistance, is rapidly replacing non-H58 <emphasis>S.</emphasis> Typhi globally (<link linkend="ch0055s0012s0003li0097">97</link>).</para>
        <para id="ch0055s0012s0001p0003">Over the past 2 decades, increasing levels of resistance to first-line antimicrobial agents among nontyphoidal<emphasis>Salmonella</emphasis> isolates have also been described, particularly among the serotypes <emphasis>S.</emphasis> Enteritidis, <emphasis>S.</emphasis> Typhimurium, <emphasis>S.</emphasis> Newport, I 4,[5],12:i:−, and <emphasis>S.</emphasis> Heidelberg (<link linkend="ch0055s0012s0003li0098">98</link>). Overall, MDR nontyphoidal <emphasis>Salmonella</emphasis> isolates in the United States remain rare. The most recent data reported by the CDC’s National Antimicrobial Resistance Monitoring System documented that 1% of 2,967 nontyphoidal <emphasis>Salmonella</emphasis> isolates displayed an MDR phenotype in 2018.</para>
        <para id="ch0055s0012s0001p0004">Resistance to the fluoroquinolones is typically mediated by alterations in the quinolone resistance-determining regions (QRDR) of the drug’s target enzymes, DNA gyrase (<emphasis>gyrA</emphasis> and <emphasis>gyrB</emphasis>) and topoisomerase IV (<emphasis>parE</emphasis> or <emphasis>parC</emphasis>). The effect of these mutations is cumulative, leading to frank resistance (MIC ≥ 4.0 μg/ml) to fluoroquinolones and to nalidixic acid (MIC ≥ 32 μg/ml) (<link linkend="ch0055s0012s0003li0099">99</link>). Plasmid-mediated quinolone resistance (PMQR) emerged in the 2000s (<link linkend="ch0055s0012s0003li0100">100</link>), including the <emphasis>qnr</emphasis> family, antibiotic efflux pump genes (<emphasis>qepA</emphasis> and <emphasis>oqxAB</emphasis>), and fluoroquinolone modification enzymes [<emphasis>acc</emphasis>(<link linkend="ch0055s0012s0003li0006">6</link>)<emphasis>Ib-cr</emphasis>]. PMQR mechanisms lead to decreased susceptibility to ciprofloxacin (MIC ≥ 0.12 μg/ml) but may not lead to resistance to nalidixic acid. Nonetheless, decreased susceptibility to ciprofloxacin has been shown to lead to treatment failure in patients with <emphasis>Salmonella</emphasis> infections (<link linkend="ch0055s0012s0003li0015">15</link>), leading both the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) to lower the <emphasis>Salmonella</emphasis> fluoroquinolone breakpoints to ≤0.06 μg/ml (ciprofloxacin) and ≤0.12 μg/ml (levofloxacin). Among nontyphoidal isolates, <emphasis>qnr</emphasis> genes are the most common PMQR determinant (<link linkend="ch0055s0012s0003li0101">101</link>, <link linkend="ch0055s0012s0003li0102">102</link>). <emphasis>qnr</emphasis> genes encode a pentapeptide repeat protein that protects type II topoisomerases from the quinolones (<link linkend="ch0055s0012s0003li0103">103</link>). Current U.S. studies demonstrate increasing levels of ciprofloxacin-nonsusceptible isolates (MIC ≥ 0.12 μg/ml) between 1999 and 2018, with 75% of <emphasis>S.</emphasis> Typhi (<emphasis>n</emphasis> = 474) and 90.5% of <emphasis>S.</emphasis> Paratyphi A (<emphasis>n</emphasis> = 121) isolates recovered in 2018 being resistant to ciprofloxacin. The XDR <emphasis>S.</emphasis> Typhi strain H58 harbors both a <emphasis>qnrS</emphasis> PMQR gene and chromosomal mutations that confer ciprofloxacin resistance. Among nontyphoidal isolates, only 9% of 2,967 tested were not susceptible to ciprofloxacin in 2018 (<link linkend="ch0055s0012s0003li0104">104</link>); the major contributor to ciprofloxacin-nonsusceptible rates was the serotype <emphasis>S.</emphasis> Enteritidis (<link linkend="ch0055s0012s0003li0098">98</link>), with 20% of cases being linked to international travel.</para>
        <para id="ch0055s0012s0001p0005">Resistance to expanded-spectrum cephalosporins in<emphasis>Salmonella</emphasis> spp. is driven by an Ambler class A, CTX-M extended-spectrum beta-lactamase (ESBL) or an Ambler class C, CMY-2 AmpC type enzyme (<link linkend="ch0055s0012s0003li0105">105</link>). XDR <emphasis>S.</emphasis> Typhi isolates harbor an IncY plasmid carrying <emphasis>bla</emphasis><subscript>CTX-M-15</subscript> (<link linkend="ch0055s0012s0003li0092">92</link>). Resistance to expanded-spectrum cephalosporins among nontyphoidal <emphasis>Salmonella</emphasis> isolates belonging to <emphasis>S.</emphasis> Typhimurium sequence type 313 has been reported in sub-Saharan Africa; these strains harbor an IncHI2 plasmid which encodes CTX-M-15 (<link linkend="ch0055s0012s0003li0106">106</link>). Sporadic global reports of carbapenem resistance in <emphasis>Salmonella</emphasis> spp. include a variety of nontyphoidal serotypes that harbor the carbapenemases KPC-2, IMP-4, NDM-1, NDM-5, VIM-2, and OXA-48 (<link linkend="ch0055s0012s0003li0107">107</link>). While carbapenem-resistant <emphasis>S.</emphasis> Typhi isolates have been reported, associated isolates have not been well characterized to date (<link linkend="ch0055s0012s0003li0096">96</link>).</para>
        <para id="ch0055s0012s0001p0006">Azithromycin, an azalide antimicrobial, has been shown in multiple randomized controlled trials to be an effective oral treatment for uncomplicated typhoid fever. Wild-type isolates of<emphasis>Salmonella</emphasis> spp. have MICs of ≤16 μg/ml, and CLSI and EUCAST have established this cutoff as the susceptible breakpoint. In contrast, isolates of <emphasis>S.</emphasis> Paratyphi A have wild-type azithromycin MICs of ≤32 μg/ml, and clinical breakpoints have not been established. Sporadic reports of <emphasis>S.</emphasis> Typhi isolates resistant to azithromycin (MIC ≥ 256 μg/ml), including the H58 haplotype, have appeared. These mutations are generally associated with the efflux pump gene <emphasis>acrB</emphasis> (<link linkend="ch0055s0012s0003li0108">108</link>, <link linkend="ch0055s0012s0003li0109">109</link>).</para>
        <para id="ch0055s0012s0001p0007">International guidance on how to approach susceptibility testing of<emphasis>Salmonella</emphasis> spp. is available from CLSI and EUCAST. CLSI recommendations are for testing <emphasis>Salmonella</emphasis> isolates from extraintestinal infections and <emphasis>S.</emphasis> Typhi and <emphasis>S.</emphasis> Paratyphi A, B, and C for susceptibility to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, and an expanded-spectrum cephalosporin. In addition, susceptibility to azithromycin may be tested and reported for extraintestinal isolates of <emphasis>Salmonella</emphasis> spp. CLSI azithromycin breakpoints are applicable only for <emphasis>S.</emphasis> Typhi (<link linkend="ch0055s0012s0003li0090">90</link>), due to the absence of data for other <emphasis>S. enterica</emphasis> serovars. In contrast, EUCAST publishes an epidemiological cutoff value (ECV) only for azithromycin and <emphasis>S.</emphasis> Typhi of ≤16 mg/ml or a ≥12-mm zone of growth inhibition surrounding a 15-μg azithromycin disk. <emphasis>Salmonella</emphasis> spp. should not be reported as susceptible to first- and second-generation cephalosporins, cephamycins, and aminoglycosides, because these are not effective clinically.</para>
        <para id="ch0055s0012s0001p0008">Historically, CLSI and EUCAST endorsed nalidixic acid screening to predict the presence of QRDR mutations in<emphasis>gyrA</emphasis> and <emphasis>parC</emphasis> in <emphasis>Salmonella</emphasis> spp. and the activity of fluoroquinolones for treatment of extraintestinal <emphasis>Salmonella</emphasis> infections and typhoid fever. However, nalidixic acid screening does not detect the plasmid-borne fluoroquinolone resistance mechanisms identified with increasing frequency in isolates of <emphasis>S. enterica</emphasis> (<link linkend="ch0055s0012s0003li0099">99</link>), including the <emphasis>qnrS</emphasis> mechanism identified in XDR <emphasis>S.</emphasis> Typhi. As an alternative, a pefloxacin disk diffusion test to predict fluoroquinolone susceptibility, as recommended by EUCAST and CLSI, can be used (<link linkend="ch0055s0012s0003li0110">110</link>, <link linkend="ch0055s0012s0003li0111">111</link>). Pefloxacin disk testing is particularly useful in low-resource countries that do not have access to MIC-based test methods and that have reported technical challenges associated with reading ciprofloxacin disk diffusion tests (<link linkend="ch0055s0012s0003li0099">99</link>). However, pefloxacin disks are not available in the United States and do not detect all fluoroquinolone resistance mechanisms, such as <emphasis>aac</emphasis>(<emphasis>6</emphasis>′)-<emphasis>Ib</emphasis>-<emphasis>cr.</emphasis> CLSI guidance indicates that the preferred test for assessing fluoroquinolone susceptibility or resistance in <emphasis>Salmonella</emphasis> spp. is ciprofloxacin or levofloxacin MIC testing, depending on the fluoroquinolone to be used therapeutically.</para>
        <anchor id="ch0055s0012s0001a0004"/>
        <beginpage pagenum="756"/>
      </sect2>
      <sect2 id="ch0055s0012s0002">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0055s0012s0002a0001"/>
        <anchor id="ch0055s0012s0002a0002"/>
        <para id="ch0055s0012s0002p0001">The genus<emphasis>Salmonella</emphasis> is a frequent pathogen of humans, most commonly causing gastroenteritis but also causing systemic infections from bloodstream infection to meningitis when infecting a susceptible host. To complicate diagnostics, variability between biochemical reactions can mislead laboratorians, and differentiation of the numerous serovars can be complicated. Use of appropriate isolation media along with novel diagnostic techniques is improving understanding of the epidemiology of this genus and will ultimately help meet the goal of improving patient care.</para>
        <para id="ch0055s0012s0002p0002">When commercial systems identify<emphasis>Salmonella</emphasis> with a high level of accuracy (&gt;90% probability), the identification is probably reliable. However, for most clinical labs, identification of <emphasis>Salmonella</emphasis> will be based on MALDI-TOF MS or phenotypic traits, which will require confirmation by O-antigen testing or molecular methods. In the interim, the isolate may be reported to the physician with a presumptive identification. Because the national surveillance systems depend on the receipt of isolates for strain typing in the United States, laboratories should follow the procedures recommended by their state health departments for reporting and submitting strains for surveillance.</para>
        <para id="ch0055s0012s0002p0003">The clinical laboratory acts as an early warning system, alerting the medical community to new resistance mechanisms present in clinically important<emphasis>Salmonella</emphasis> isolates. Similar to other members of the order <emphasis>Enterobacterales</emphasis>, an increasing number of <emphasis>Salmonella</emphasis> isolates are reported to carry ESBLs and carbapenemases. The ability to recognize these isolates is critical for patient care and effective infection prevention measures.</para>
      </sect2>
      <sect2 id="ch0055s0012s0003">
        <title>REFERENCES</title>
        <anchor id="ch0055s0012s0003a0001"/>
        <anchor id="ch0055s0012s0003a0002"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0055s0012s0003li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Hohmann EL.</emphasis> 2001. Nontyphoidal salmonellosis. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">32:</emphasis>263–269.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Reeves MW, Evins GM, Heiba AA, Plikaytis BD, Farmer JJ III.</emphasis> 1989. Clonal nature of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of <citetitle><emphasis>Salmonella bongori</emphasis></citetitle> comb. nov. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">27:</emphasis>313–320.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Crosa JH, Brenner DJ, Ewing WH, Falkow S.</emphasis> 1973. Molecular relationships among the salmonelleae. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">115:</emphasis>307–315.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Baker S, Dougan G.</emphasis> 2007. The genome of <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovar Typhi. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">45</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>S29–S33.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Laing CR, Whiteside MD, Gannon VPJ.</emphasis> 2017. Pan-genome analyses of the species <citetitle><emphasis>Salmonella enterica</emphasis></citetitle>, and identification of genomic markers predictive for species, subspecies, and serovar. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>1345.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Wain J, House D, Zafar A, Baker S, Nair S, Kidgell C, Bhutta Z, Dougan G, Hasan R.</emphasis> 2005. Vi antigen expression in <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovar Typhi clinical isolates from Pakistan. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>1158–1165.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Partridge JD, Harshey RM.</emphasis> 2013. More than motility: <citetitle><emphasis>Salmonella</emphasis></citetitle> flagella contribute to overriding friction and facilitating colony hydration during swarming. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">195:</emphasis>919–929.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Ledeboer NA, Frye JG, McClelland M, Jones BD.</emphasis> 2006. <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovar Typhimurium requires the Lpf, Pef, and Tafi fimbriae for biofilm formation on HEp-2 tissue culture cells and chicken intestinal epithelium. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">74:</emphasis>3156–3169.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Brenner FW, Villar RG, Angulo FJ, Tauxe R, Swaminathan B.</emphasis> 2000. <citetitle><emphasis>Salmonella</emphasis></citetitle> nomenclature. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>2465–2467.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Tindall BJ, Grimont PAD, Garrity GM, Euzéby JP.</emphasis> 2005. Nomenclature and taxonomy of the genus <citetitle><emphasis>Salmonella. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>521–524.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ, Jones TF, Fazil A, Hoekstra RM, International Collaboration on Enteric Disease ‘Burden of Illness’ Studies.</emphasis> 2010. The global burden of nontyphoidal Salmonella gastroenteritis. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">50:</emphasis>882–889.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Boore AL, Hoekstra RM, Iwamoto M, Fields PI, Bishop RD, Swerdlow DL.</emphasis> 2015. <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> infections in the United States and assessment of coefficients of variation: a novel approach to identify epidemiologic characteristics of individual serotypes, 1996-2011. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">10</emphasis><emphasis role="strong">:</emphasis>e0145416.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM.</emphasis> 2011. Foodborne illness acquired in the United States—major pathogens. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>7–15.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Eng S-K, Pusparajah P, Ab Mutalib N-S, Ser H-L, Chan K-G, Lee L-H.</emphasis> 2015. <citetitle><emphasis>Salmonella</emphasis></citetitle>: a review on pathogenesis, epidemiology and antibiotic resistance. <citetitle><emphasis>Front Life Sci</emphasis></citetitle> <emphasis role="strong">8</emphasis><emphasis role="strong">:</emphasis>284–293.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, Segler SD, Megginson M, Luedeman LJ, Shiferaw B, Hanna SS, Joyce KW, Mintz ED, Angulo FJ, Emerging Infections Program FoodNet and NARMS Working Groups.</emphasis> 2008. Clinical response and outcome of infection with <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicenter retrospective cohort study. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1278–1284.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Marshall KE, Nguyen TA, Ablan M, Nichols MC, Robyn MP, Sundararaman P, Whitlock L, Wise ME, Jhung MA.</emphasis> 2020. Investigations of possible multistate outbreaks of <citetitle><emphasis>Salmonella</emphasis></citetitle>, Shiga toxin-producing <citetitle><emphasis>Escherichia coli</emphasis></citetitle>, and <citetitle><emphasis>Listeria monocytogenes</emphasis></citetitle> infections—United States, 2016. <citetitle><emphasis>MMWR Surveill Summ</emphasis></citetitle> <emphasis role="strong">69:</emphasis>1–14.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Kothary MH, Babu US.</emphasis> 2001. Infective dose of foodborne pathogens in volunteers: a review. <citetitle><emphasis>J Food Saf</emphasis></citetitle> <emphasis role="strong">21:</emphasis>49–68.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Kramer A, Schwebke I, Kampf G.</emphasis> 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">6:</emphasis>130.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Gonzalez-Escobedo G, Marshall JM, Gunn JS.</emphasis> 2011. Chronic and acute infection of the gall bladder by <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi: understanding the carrier state. <citetitle><emphasis>Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">9:</emphasis>9–14.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF.</emphasis> 1987. Incidence of salmonellosis in patients with AIDS. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">156</emphasis><emphasis role="strong">:</emphasis>998–1002.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Yen YF, Wang FD, Chiou CS, Chen YY, Lin ML, Chen TL, Liu CY.</emphasis> 2009. Prognostic factors and clinical features of non-typhoid <citetitle><emphasis>Salmonella</emphasis></citetitle> bacteremia in adults. <citetitle><emphasis>J Chin Med Assoc</emphasis></citetitle> <emphasis role="strong">72:</emphasis>408–413.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Yen YF, Lin YC, Chen TL, Chen YY, Lin ML, Wang FD, Liu CY.</emphasis> 2007. Non-typhoidal <citetitle><emphasis>Salmonella</emphasis></citetitle> bacteremia in adults. <citetitle><emphasis>J Microbiol Immunol Infect</emphasis></citetitle> <emphasis role="strong">40</emphasis><emphasis role="strong">:</emphasis>227–233.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ.</emphasis> 2002. Typhoid fever. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">347:</emphasis>1770–1782.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Ly KT, Casanova JE.</emphasis> 2007. Mechanisms of <citetitle><emphasis>Salmonella</emphasis></citetitle> entry into host cells. <citetitle><emphasis>Cell Microbiol</emphasis></citetitle> <emphasis role="strong">9:</emphasis>2103–2111.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0025" role="bibliographyEntry">
            <anchor id="ch0055s0012s0003a0003"/>
            <para>25.<emphasis role="strong">Andrews-Polymenis HL, Bäumler AJ, McCormick BA, Fang FC.</emphasis> 2010. Taming the elephant: <citetitle><emphasis>Salmonella</emphasis></citetitle> biology, pathogenesis, and prevention. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">78:</emphasis>2356–2369.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Song J, Gao X, Galán JE.</emphasis> 2013. Structure and function of the <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi chimaeric A(2)B(5) typhoid toxin. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">499:</emphasis>350–354.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Leber AL (ed).</emphasis> 2016. <citetitle><emphasis>Clinical Microbiology Procedures Handbook</emphasis></citetitle>, 4th ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Kotton CN, Lankowski AJ, Hohmann EL.</emphasis> 2006. Comparison of rectal swabs with fecal cultures for detection of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhimurium in adult volunteers. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">56:</emphasis>123–126.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Silbert S, Gostnell A, Kubasek C, Widen R.</emphasis> 2017. Evaluation of the new FecalSwab system for maintaining stability of stool samples submitted for molecular tests. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1588–1590.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Freedman SB, Xie J, Nettel-Aguirre A, Lee B, Chui L, Pang XL, Zhuo R, Parsons B, Dickinson JA, Vanderkooi OG, Ali S, Osterreicher L, Lowerison K, Tarr PI, Chuck A, Currie G, Eltorki M, Graham T, Jiang J, Johnson D, Kellner J, Lavoie M, Louie M, MacDonald J, MacDonald S, Simmonds K, Svenson L, Tellier R, Drews S, Talbot J, Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE).</emphasis> 2017. Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study. <citetitle><emphasis>Lancet Gastroenterol Hepatol</emphasis></citetitle> <emphasis role="strong">2:</emphasis>662–669.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Richard-Greenblatt M, Rutherford C, Luinstra K, Cárdenas AM, Pang XL, Jayaratne P, Smieja M.</emphasis> 2020. Evaluation of the FecalSwab for stool specimen storage and molecular detection of enteropathogens on the BD Max system. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>e00178-20.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Humphries RM, Linscott AJ.</emphasis> 2015. Practical guidance for clinical microbiology laboratories: diagnosis of bacterial gastroenteritis. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">28:</emphasis>3–31.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Church DL, Cadrain G, Kabani A, Jadavji T, Trevenen C.</emphasis> 1995. Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children’s Hospital, Calgary, Alberta, Canada. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">103:</emphasis>149–153.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Gilligan PA, Karmali MA, Miller JM.</emphasis> 1992. <citetitle><emphasis>Cumitech 12A. Laboratory Diagnosis of Bacterial Diarrhea.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Siegel DL, Edelstein PH, Nachamkin I.</emphasis> 1990. Inappropriate testing for diarrheal diseases in the hospital. <citetitle><emphasis>JAMA</emphasis></citetitle> <emphasis role="strong">263:</emphasis>979–982.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Hitchcock MM, Gomez CA, Banaei N.</emphasis> 2018. Low yield of FilmArray GI panel in hospitalized patients with diarrhea: an opportunity for diagnostic stewardship intervention. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>e01558-17.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Park S, Hitchcock MM, Gomez CA, Banaei N.</emphasis> 2017. Is follow-up testing with the FilmArray gastrointestinal multiplex PCR panel necessary? <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1154–1161.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Gasem MH, Dolmans WM, Isbandrio BB, Wahyono H, Keuter M, Djokomoeljanto R.</emphasis> 1995. Culture of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi and <citetitle><emphasis>Salmonella</emphasis></citetitle> Paratyphi from blood and bone marrow in suspected typhoid fever. <citetitle><emphasis>Trop Geogr Med</emphasis></citetitle> <emphasis role="strong">47</emphasis><emphasis role="strong">:</emphasis>164–167.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Gilman RH, Terminel M, Levine MM, Hernandez-Mendoza P, Hornick RB.</emphasis> 1975. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi in typhoid fever. <citetitle><emphasis>Lancet</emphasis></citetitle> <emphasis role="strong">i:</emphasis>1211–1213.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Vallenas C, Hernandez H, Kay B, Black R, Gotuzzo E.</emphasis> 1985. Efficacy of bone marrow, blood, stool and duodenal contents cultures for bacteriologic confirmation of typhoid fever in children. <citetitle><emphasis>Pediatr Infect Dis</emphasis></citetitle> <emphasis role="strong">4:</emphasis>496–498.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Liss MA, Peeples AN, Peterson EM.</emphasis> 2011. Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1116–1118.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Croft CC, Miller MJ.</emphasis> 1956. Isolation of <citetitle><emphasis>Shigella</emphasis></citetitle> from rectal swabs with Hajna GN broth. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">26</emphasis>(4_ts)<emphasis role="strong">:</emphasis>411–417.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Srijan A, Bodhidatta L, Mason C.</emphasis> 2015. Efficiency of plating media and enrichment broths for isolating <citetitle><emphasis>Salmonella</emphasis></citetitle> species from human stool samples: a comparison study. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">5:</emphasis>231–236.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Boer MD, de Boer RF, Lameijer A, Sterne E, Skidmore B, Suijkerbuijk AWM, Heck M, van der Zanden AGM.</emphasis> 2019. Selenite enrichment broth to improve the sensitivity in molecular diagnostics of <citetitle><emphasis>Salmonella. J Microbiol Methods</emphasis></citetitle> <emphasis role="strong">157:</emphasis>59–64.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Digestive Ferments Company DL.</emphasis> 1998. Difco manual of dehydrated culture media and reagents for microbiological and clinical laboratory procedures.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Taylor WI, Schelhart D.</emphasis> 1971. Isolation of shigellae. VIII. Comparison of xylose lysine deoxycholate agar, Hektoen enteric agar, <citetitle><emphasis>Salmonella</emphasis></citetitle>-<citetitle><emphasis>Shigella</emphasis></citetitle> agar, and eosin methylene blue agar with stool specimens. <citetitle><emphasis>Appl Microbiol</emphasis></citetitle> <emphasis role="strong">21:</emphasis>32–37.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">van Dijk S, Bruins MJ, Ruijs GJ.</emphasis> 2009. Evaluation and implementation of a chromogenic agar medium for <citetitle><emphasis>Salmonella</emphasis></citetitle> detection in stool in routine laboratory diagnostics. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>456–458.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Singh BR, Singh VP, Agarwal M, Sharma G, Chandra M.</emphasis> 2004. Haemolysins of <citetitle><emphasis>Salmonella</emphasis></citetitle>, their role in pathogenesis and subtyping of <citetitle><emphasis>Salmonella</emphasis></citetitle> serovars. <citetitle><emphasis>Indian J Exp Biol</emphasis></citetitle> <emphasis role="strong">42</emphasis><emphasis role="strong">:</emphasis>303–313.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Farmer JJ III, Davis BR, Hickman-Brenner FW, McWhorter A, Huntley-Carter GP, Asbury MA, Riddle C, Wathen-Grady HG, Elias C, Fanning GR.</emphasis> 1985. Biochemical identification of new species and biogroups of <citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> isolated from clinical specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">21:</emphasis>46–76.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">O’Hara CM, Miller JM.</emphasis> 2003. Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family <citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>2096–2101.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">O’Hara CM, Miller JM.</emphasis> 2000. Evaluation of the MicroScan rapid neg ID3 panel for identification of <citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> and some common gram-negative nonfermenters. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>3577–3580.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">O’Hara CM.</emphasis> 2006. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of <citetitle><emphasis>Enterobacteriaceae, Vibrionaceae</emphasis></citetitle>, and commonly isolated nonenteric gram-negative bacilli. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>928–933.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Faron ML, Buchan BW, Hyke J, Madisen N, Lillie JL, Granato PA, Wilson DA, Procop GW, Novak-Weekley S, Marlowe E, Cumpio J, Griego-Fullbright C, Kindig S, Timm K, Young S, Ledeboer NA.</emphasis> 2015. Multicenter evaluation of the Bruker MALDI Biotyper CA system for the identification of clinical aerobic Gram-negative bacterial isolates. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">10</emphasis><emphasis role="strong">:</emphasis>e0141350.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">He Y, Li H, Lu X, Stratton CW, Tang YW.</emphasis> 2010. Mass spectrometry biotyper system identifies enteric bacterial pathogens directly from colonies grown on selective stool culture media. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>3888–3892.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Leuschner RG, Beresford-Jones N, Robinson C.</emphasis> 2004. Difference and consensus of whole cell <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> subsp. <citetitle><emphasis>enterica</emphasis></citetitle> serovars matrix-assisted laser desorption/ionization time-of-flight mass spectrometry spectra. <citetitle><emphasis>Lett Appl Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>24–31.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Dieckmann R, Malorny B.</emphasis> 2011. Rapid screening of epidemiologically important <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> subsp. <citetitle><emphasis>enterica</emphasis></citetitle> serovars by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">77:</emphasis>4136–4146.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Porte L, García P, Braun S, Ulloa MT, Lafourcade M, Montaña A, Miranda C, Acosta-Jamett G, Weitzel T.</emphasis> 2017. Head-to-head comparison of Microflex LT and Vitek MS systems for routine identification of microorganisms by MALDI-TOF mass spectrometry in Chile. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">12</emphasis><emphasis role="strong">:</emphasis>e0177929.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, Rogatcheva M, Kanack KJ, Bourzac KM.</emphasis> 2015. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>915–925.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Buchan BW, Olson WJ, Pezewski M, Marcon MJ, Novicki T, Uphoff TS, Chandramohan L, Revell P, Ledeboer NA.</emphasis> 2013. Clinical evaluation of a real-time PCR assay for identification of <citetitle><emphasis>Salmonella, Shigella, Campylobacter</emphasis></citetitle> (<citetitle><emphasis>Campylobacter jejuni</emphasis></citetitle> and <citetitle><emphasis>C. coli</emphasis></citetitle>), and Shiga toxin-producing <citetitle><emphasis>Escherichia coli</emphasis></citetitle> isolates in stool specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>4001–4007.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Claas EC, Burnham CA, Mazzulli T, Templeton K, Topin F.</emphasis> 2013. Performance of the xTAG<superscript>®</superscript> gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. <citetitle><emphasis>J Microbiol Biotechnol</emphasis></citetitle> <emphasis role="strong">23:</emphasis>1041–1045.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Harrington SM, Buchan BW, Doern C, Fader R, Ferraro MJ, Pillai DR, Rychert J, Doyle L, Lainesse A, Karchmer T, Mortensen JE.</emphasis> 2015. Multicenter evaluation of the BD Max enteric bacterial panel PCR assay for rapid detection of <citetitle><emphasis>Salmonella</emphasis></citetitle> spp.<citetitle><emphasis>, Shigella</emphasis></citetitle> spp.<citetitle><emphasis>, Campylobacter</emphasis></citetitle> spp. (<citetitle><emphasis>C. jejuni</emphasis></citetitle> and <citetitle><emphasis>C. coli</emphasis></citetitle>), and Shiga toxin 1 and 2 genes. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>1639–1647.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Anderson NW, Buchan BW, Ledeboer NA.</emphasis> 2014. Comparison of the BD MAX enteric bacterial panel to routine culture methods for detection of <citetitle><emphasis>Campylobacter</emphasis></citetitle>, enterohemorrhagic <citetitle><emphasis>Escherichia coli</emphasis></citetitle> (O157), <citetitle><emphasis>Salmonella,</emphasis></citetitle> and <citetitle><emphasis>Shigella</emphasis></citetitle> isolates in preserved stool specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1222–1224.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Riddle MS, DuPont HL, Connor BA.</emphasis> 2016. ACG clinical guideline: Diagnosis, treatment, and prevention of acute diarrheal infections in adults. <citetitle><emphasis>Am J Gastroenterol</emphasis></citetitle> <emphasis role="strong">111:</emphasis>602–622.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Mortensen JE, Ventrola C, Hanna S, Walter A.</emphasis> 2015. Comparison of time-motion analysis of conventional stool culture and the BD MAX™ enteric bacterial panel (EBP). <citetitle><emphasis>BMC Clin Pathol</emphasis></citetitle> <emphasis role="strong">15:</emphasis>9.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK.</emphasis> 2017. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">65:</emphasis>1963–1973.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Laupland KB, Schønheyder HC, Kennedy KJ, Lyytikäinen O, Valiquette L, Galbraith J, Collignon P, International Bacteremia Surveillance Collaborative.</emphasis> 2010. <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> bacteraemia: a multi-national population-based cohort study. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">10:</emphasis>95.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Crump JA, Heyderman RS.</emphasis> 2015. A perspective on invasive <citetitle><emphasis>Salmonella</emphasis></citetitle> disease in Africa. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">61</emphasis>(Suppl 4)<emphasis role="strong">:</emphasis>S235–S240.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Altun O, Almuhayawi M, Ullberg M, Ozenci V.</emphasis> 2013. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>4130–4136.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Bryant S, Almahmoud I, Pierre I, Bardet J, Touati S, Maubon D, Cornet M, Richarme C, Maurin M, Pavese P, Caspar Y.</emphasis> 2020. Evaluation of microbiological performance and the potential clinical impact of the ePlex<superscript>®</superscript> blood culture identification panels for the rapid diagnosis of bacteremia and fungemia. <citetitle><emphasis>Front Cell Infect Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>594951.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Wolk DM, Young S, Whitfield NN, Reid JL, Thornberg A, Carroll KC, Buchan BW, Davis TE, Salimnia H.</emphasis> 2021. A multicenter clinical study to demonstrate the diagnostic accuracy of the GenMark Dx ePlex blood culture identification GramnNegative panel. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>e02484-20.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Grimont P, François-Xavier W.</emphasis> 2007. <citetitle><emphasis>Antigenic Formulae of the Salmonella Serovars.</emphasis></citetitle> WHO Collaborating Centre for Reference and Research on Salmonella, Paris, France.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Issenhuth-Jeanjean S, Roggentin P, Mikoleit M, Guibourdenche M,</emphasis> de <emphasis role="strong">Pinna E, Nair S, Fields PI, Weill FX.</emphasis> 2014. Supplement 2008-2010 (no. 48) to the White-Kauffmann-Le Minor scheme. <citetitle><emphasis>Res Microbiol</emphasis></citetitle> <emphasis role="strong">165:</emphasis>526–530.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Dekker JP, Frank KM.</emphasis> 2015. <citetitle><emphasis>Salmonella, Shigella</emphasis></citetitle>, and <citetitle><emphasis>Yersinia. Clin Lab Med</emphasis></citetitle> <emphasis role="strong">35:</emphasis>225–246.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Shi C, Singh P, Ranieri ML, Wiedmann M, Moreno Switt AI.</emphasis> 2015. Molecular methods for serovar determination of <citetitle><emphasis>Salmonella. Crit Rev Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>309–325.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Silverman M, Zieg J, Hilmen M, Simon M.</emphasis> 1979. Phase variation in <citetitle><emphasis>Salmonella</emphasis></citetitle>: genetic analysis of a recombinational switch. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">76:</emphasis>391–395.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Zieg J, Silverman M, Hilmen M, Simon M.</emphasis> 1977. Recombinational switch for gene expression. <citetitle><emphasis>Science</emphasis></citetitle> <emphasis role="strong">196:</emphasis>170–172.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Mortimer CK, Peters TM, Gharbia SE, Logan JM, Arnold C.</emphasis> 2004. Towards the development of a DNA-sequence based approach to serotyping of <citetitle><emphasis>Salmonella enterica. BMC Microbiol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>31.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Snellings NJ, Johnson EM, Kopecko DJ, Collins HH, Baron LS.</emphasis> 1981. Genetic regulation of variable Vi antigen expression in a strain of <citetitle><emphasis>Citrobacter freundii. J Bacteriol</emphasis></citetitle> <emphasis role="strong">145:</emphasis>1010–1017.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Bale J, Meunier D, Weill FX, dePinna E, Peters T, Nair S.</emphasis> 2016. Characterization of new <citetitle><emphasis>Salmonella</emphasis></citetitle> serovars by whole-genome sequencing and traditional typing techniques. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>1074–1078.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Achtman M, Wain J, Weill FX, Nair S, Zhou Z, Sangal V, Krauland MG, Hale JL, Harbottle H, Uesbeck A, Dougan G, Harrison LH, Brisse S, Group SEMS, S. Enterica MLST Study Group.</emphasis> 2012. Multilocus sequence typing as a replacement for serotyping in <citetitle><emphasis>Salmonella enterica. PLoS Pathog</emphasis></citetitle> <emphasis role="strong">8</emphasis><emphasis role="strong">:</emphasis>e1002776.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Yoshida CE, Kruczkiewicz P, Laing CR, Lingohr EJ, Gannon VP, Nash JH, Taboada EN.</emphasis> 2016. The <citetitle><emphasis>Salmonella</emphasis></citetitle> In Silico Typing Resource (SISTR): an open web-accessible tool for rapidly typing and subtyping draft <citetitle><emphasis>Salmonella</emphasis></citetitle> genome assemblies. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">11</emphasis><emphasis role="strong">:</emphasis>e0147101.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Zhang S, Yin Y, Jones MB, Zhang Z, Deatherage Kaiser BL, Dinsmore BA, Fitzgerald C, Fields PI, Deng X.</emphasis> 2015. <citetitle><emphasis>Salmonella</emphasis></citetitle> serotype determination utilizing high-throughput genome sequencing data. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>1685–1692.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Franklin K, Lingohr EJ, Yoshida C, Anjum M, Bodrossy L, Clark CG, Kropinski AM, Karmali MA.</emphasis> 2011. Rapid genoserotyping tool for classification of <citetitle><emphasis>Salmonella</emphasis></citetitle> serovars. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>2954–2965.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Yachison CA, Yoshida C, Robertson J, Nash JHE, Kruczkiewicz P, Taboada EN, Walker M, Reimer A, Christianson S, Nichani A, Nadon C, PulseNet Canada Steering Committee.</emphasis> 2017. The validation and implications of using whole genome sequencing as a replacement for traditional serotyping for a national <citetitle><emphasis>Salmonella</emphasis></citetitle> reference laboratory. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>1044.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Ashton PM, Peters T, Ameh L, McAleer R, Petrie S, Nair S, Muscat I,</emphasis> de <emphasis role="strong">Pinna E, Dallman T.</emphasis> 2015. Whole genome sequencing for the retrospective investigation of an outbreak of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhimurium DT 8. <citetitle><emphasis>PLoS Curr</emphasis></citetitle> <emphasis role="strong">7:</emphasis>ecurrents.outbreaks.2c05a47d292f376afc5a6fcdd8a7a3b6.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Hoffmann M, Luo Y, Monday SR, Gonzalez-Escalona N, Ottesen AR, Muruvanda T, Wang C, Kastanis G, Keys C, Janies D, Senturk IF, Catalyurek UV, Wang H, Hammack TS, Wolfgang WJ, Schoonmaker-Bopp D, Chu A, Myers R, Haendiges J, Evans PS, Meng J, Strain EA, Allard MW, Brown EW.</emphasis> 2016. Tracing origins of the <citetitle><emphasis>Salmonella</emphasis></citetitle> Bareilly strain causing a food-borne outbreak in the United States. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">213:</emphasis>502–508.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Wilson MR, Brown E, Keys C, Strain E, Luo Y, Muruvanda T, Grim C, Jean-Gilles Beaubrun J, Jarvis K, Ewing L, Gopinath G, Hanes D, Allard MW, Musser S.</emphasis> 2016. Whole genome DNA sequence analysis of <citetitle><emphasis>Salmonella</emphasis></citetitle> subspecies <citetitle><emphasis>enterica</emphasis></citetitle> serotype Tennessee obtained from related peanut butter foodborne outbreaks. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">11</emphasis><emphasis role="strong">:</emphasis>e0146929.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Inns T, Ashton PM, Herrera-Leon S, Lighthill J, Foulkes S, Jombart T, Rehman Y, Fox A, Dallman T, DE Pinna E, Browning L, Coia JE, Edeghere O, Vivancos R.</emphasis> 2017. Prospective use of whole genome sequencing (WGS) detected a multi-country outbreak of <citetitle><emphasis>Salmonella</emphasis></citetitle> Enteritidis. <citetitle><emphasis>Epidemiol Infect</emphasis></citetitle> <emphasis role="strong">145:</emphasis>289–298.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Trishkova LA, Nagornaia SP.</emphasis> 1977. Comparative evaluation of biochemical study methods in the diagnosis of biliary tract lesions in viral hepatitis in children. <citetitle><emphasis>Pediatr Akus Ginekol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>22–23. (In Ukrainian.)</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0090" role="bibliographyEntry">
            <para>90. CLSI. 2007. Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S17. CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Crump JA, Sjölund-Karlsson M, Gordon MA, Parry CM.</emphasis> 2015. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive <citetitle><emphasis>Salmonella</emphasis></citetitle> infections. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">28:</emphasis>901–937.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, Wong VK, Dallman TJ, Nair S, Baker S, Shaheen G, Qureshi S, Yousafzai MT, Saleem MK, Hasan Z, Dougan G, Hasan R.</emphasis> 2018. Emergence of an extensively drug-resistant <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. <citetitle><emphasis>mBio</emphasis></citetitle> <emphasis role="strong">9:</emphasis>e00105-18.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0093" role="bibliographyEntry">
            <anchor id="ch0055s0012s0003a0004"/>
            <para>93.<emphasis role="strong">World Health Organization.</emphasis> 2019. Drug resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> infections in Pakistan: update. <ulink url="https://reliefweb.int/sites/reliefweb.int/files/resources/Epi_Monitor_2019_12_34.pdf">https://reliefweb.int/sites/reliefweb.int/files/resources/Epi_Monitor_2019_12_34.pdf</ulink>. Accessed April 2022.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">François Watkins LK, Winstead A, Appiah GD, Friedman CR, Medalla F, Hughes MJ, Birhane MG, Schneider ZD, Marcenac P, Hanna SS, Godbole G, Walblay KA, Wiggington AE, Leeper M, Meservey EH, Tagg KA, Chen JC, Abubakar A, Lami F, Asaad AM, Sabaratnam V, Ikram A, Angelo KM, Walker A, Mintz E.</emphasis> 2020. Update on extensively drug-resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> serotype Typhi infections among travelers to or from Pakistan and report of ceftriaxone-resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> serotype Typhi infections among travelers to Iraq—United States, 2018-2019. <citetitle><emphasis>MMWR Morb Mortal Wkly Rep</emphasis></citetitle> <emphasis role="strong">69:</emphasis>618–622.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Health Alert Network, Centers for Disease Control and Prevention.</emphasis> 2021. Extensively drug-resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi infections among U.S. residents without international travel. <ulink url="https://emergency.cdc.gov/han/2021/han00439.asp">https://emergency.cdc.gov/han/2021/han00439.asp</ulink>. Accessed April 2022.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Marchello CS, Carr SD, Crump JA.</emphasis> 2020. A systematic review on antimicrobial resistance among <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi worldwide. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">103:</emphasis>2518–2527.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, et al.</emphasis> 2015. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi identifies inter- and intracontinental transmission events. <citetitle><emphasis>Nat Genet</emphasis></citetitle> <emphasis role="strong">47:</emphasis>632–639.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Medalla F, Gu W, Friedman CR, Judd M, Folster J, Griffin PM, Hoekstra RM.</emphasis> 2021. Increased incidence of antimicrobial-resistant nontyphoidal <citetitle><emphasis>Salmonella</emphasis></citetitle> infections, United States, 2004-2016. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1662–1672.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Humphries RM, Fang FC, Aarestrup FM, Hindler JA.</emphasis> 2012. In vitro susceptibility testing of fluoroquinolone activity against <citetitle><emphasis>Salmonella</emphasis></citetitle>: recent changes to CLSI standards. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1107–1113.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Robicsek A, Jacoby GA, Hooper DC.</emphasis> 2006. The worldwide emergence of plasmid-mediated quinolone resistance. <citetitle><emphasis>Lancet Infect Dis</emphasis></citetitle> <emphasis role="strong">6:</emphasis>629–640.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Kim J, Han X, Bae J, Chui L, Louie M, Finley R, Mulvey MR, Ferrato CJ, Jeon B.</emphasis> 2016. Prevalence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal <citetitle><emphasis>Salmonella</emphasis></citetitle> strains with resistance and reduced susceptibility to fluoroquinolones from human clinical cases in Alberta, Canada, 2009-13. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">71:</emphasis>2988–2990.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Campbell D, Tagg K, Bicknese A, McCullough A, Chen J, Karp BE, Folster JP.</emphasis> 2018. Identification and characterization of <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serotype Newport isolates with decreased susceptibility to ciprofloxacin in the United States. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">62:</emphasis>e00653-18.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Martínez-Martínez L, Pascual A, Jacoby GA.</emphasis> 1998. Quinolone resistance from a transferable plasmid. <citetitle><emphasis>Lancet</emphasis></citetitle> <emphasis role="strong">351:</emphasis>797–799.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Centers for Disease Control and Prevention.</emphasis> <citetitle><emphasis>NARMS database</emphasis></citetitle>. <ulink url="https://wwwn.cdc.gov/NARMSNow/Main/AdvReports">https://wwwn.cdc.gov/NARMSNow/Main/AdvReports</ulink>. Accessed April 2022.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Yan JJ, Ko WC, Chiu CH, Tsai SH, Wu HM, Wu JJ.</emphasis> 2003. Emergence of ceftriaxone-resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">9</emphasis><emphasis role="strong">:</emphasis>323–328.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Kariuki S, Okoro C, Kiiru J, Njoroge S, Omuse G, Langridge G, Kingsley RA, Dougan G, Revathi G.</emphasis> 2015. Ceftriaxone-resistant <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serotype Typhimurium sequence type 313 from Kenyan patients is associated with the <citetitle><emphasis>blaCTX-M-15</emphasis></citetitle> gene on a novel IncHI2 plasmid. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">59:</emphasis>3133–3139.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Fernández J, Guerra B, Rodicio MR.</emphasis> 2018. Resistance to carbapenems in nontyphoidal <citetitle><emphasis>Salmonella enterica</emphasis></citetitle> serovars from humans, animals and food. <citetitle><emphasis>Vet Sci</emphasis></citetitle> <emphasis role="strong">5:</emphasis>40.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Hooda Y, Sajib MSI, Rahman H, Luby SP, Bondy-Denomy J, Santosham M, Andrews JR, Saha SK, Saha S.</emphasis> 2019. Molecular mechanism of azithromycin resistance among typhoidal <citetitle><emphasis>Salmonella</emphasis></citetitle> strains in Bangladesh identified through passive pediatric surveillance. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">13</emphasis><emphasis role="strong">:</emphasis>e0007868.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Duy PT, Dongol S, Giri A, Nguyen To NT, Dan Thanh HN, Nhu Quynh NP, Duc Trung P, Thwaites GE, Basnyat B, Baker S, Rabaa MA, Karkey A.</emphasis> 2020. The emergence of azithromycin-resistant <citetitle><emphasis>Salmonella</emphasis></citetitle> Typhi in Nepal. JAC Antimicrob Resist 4:dlaa109.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Skov R, Matuschek E, Sjölund-Karlsson M, Åhman J, Petersen A, Stegger M, Torpdahl M, Kahlmeter G.</emphasis> 2015. Development of a pefloxacin disk diffusion method for detection of fluoroquinolone-resistant <citetitle><emphasis>Salmonella enterica. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>3411–3417.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">EUCAST.</emphasis> 2022. European Commitee on Antimicrobial Susceptibility Testing breakpoint tables for interpretation of MICs and zone diameters. Version 12. <ulink url="https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_12.0_Breakpoint_Tables.pdf">https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_12.0_Breakpoint_Tables.pdf</ulink>. Accessed April 2022.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Ewing W.</emphasis> 1986. <citetitle><emphasis>Edwards and Ewing’s Identification of Enterobacteriaceae</emphasis></citetitle>, 4th ed. Elsevier Scientific Publishing Co., Inc, New York, NY.</para>
          </listitem>
          <listitem id="ch0055s0012s0003li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">CDC.</emphasis> 2018. National Enteric Disease Surveillance: <citetitle><emphasis>Salmonella</emphasis></citetitle> annual report, 2016. <ulink url="https://www.cdc.gov/nationalsurveillance/pdfs/2016-Salmonella-report-508.pdf">https://www.cdc.gov/nationalsurveillance/pdfs/2016-Salmonella-report-508.pdf</ulink>. Accessed April 2022.</para>
          </listitem>
        </itemizedlist>
        <anchor id="ch0055s0012s0003a0005"/>
        <beginpage pagenum="758"/>
      </sect2>
    </sect1>
  </chapter>
